data_2mlj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mlj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.834 -0.603 . . . . 72.439999999999998 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.63 31.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.848 -0.427 . . . . 73.25 109.848 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.44 166.94 12.32 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 108.935 -1.666 . . . . 75.450000000000003 108.935 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.0 14.8 9.2 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 124.432 0.724 . . . . 73.439999999999998 110.839 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.2 t -59.83 -172.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.873 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.33 58.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.761 . . . . 71.310000000000002 112.465 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.69 115.85 31.24 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 118.535 -2.744 . . . . 74.230000000000004 105.599 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.21 150.22 48.57 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.862 1.664 . . . . 75.219999999999999 106.74 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.26 -45.99 65.29 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 119.905 1.23 . . . . 71.349999999999994 108.312 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -130.37 167.15 19.01 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.008 0.817 . . . . 74.549999999999997 109.145 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.4 mmt -69.13 -38.56 78.92 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 118.374 -0.822 . . . . 73.310000000000002 110.42 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 t -82.86 -52.76 6.43 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.132 0.878 . . . . 74.010000000000005 112.524 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -70.67 177.19 3.65 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 119.51 1.05 . . . . 65.140000000000001 112.028 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 pm0 -121.2 49.01 1.55 Allowed 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.246 -0.65 . . . . 75.319999999999993 109.246 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -118.67 171.03 8.47 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 116.899 -1.524 . . . . 61.420000000000002 107.884 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 5' ' ' SER . 19.1 m-85 -139.28 160.18 40.43 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.038 1.29 . . . . 71.420000000000002 110.238 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -81.96 151.06 66.59 Favored Pre-proline 0 C--N 1.356 0.884 0 CA-C-O 116.358 -1.782 . . . . 75.439999999999998 108.151 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 C--N 1.36 1.174 0 CA-C-N 122.793 2.033 . . . . 74.109999999999999 110.133 179.241 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 118.875 -0.583 . . . . 72.420000000000002 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.75 33.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.696 -0.483 . . . . 72.109999999999999 109.696 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.65 12.18 Favored Glycine 0 C--N 1.354 1.537 0 N-CA-C 109.047 -1.621 . . . . 72.040000000000006 109.047 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.69 15.14 9.45 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 124.397 0.704 . . . . 70.209999999999994 110.823 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -59.67 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.530000000000001 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.27 6.2 61.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.299999999999997 112.49 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.49 102.72 12.17 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 119.203 -2.351 . . . . 74.439999999999998 106.09 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -57.48 150.42 18.8 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.099 1.318 . . . . 72.0 109.438 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -71.44 -51.32 24.5 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 107.36 -1.348 . . . . 73.209999999999994 107.36 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 p -125.72 162.77 24.3 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.045 0.841 . . . . 74.310000000000002 109.829 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -64.68 -35.42 80.97 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.375 -0.821 . . . . 73.109999999999999 111.788 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -85.74 -51.2 6.59 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 119.074 0.852 . . . . 74.120000000000005 112.298 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -72.89 176.82 5.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.098 0.863 . . . . 72.140000000000001 111.811 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 52.44 1.25 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.728 -0.842 . . . . 75.319999999999993 108.728 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 t -122.91 170.51 10.05 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 116.799 -1.572 . . . . 75.140000000000001 107.499 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 5' ' ' SER . 23.9 m-85 -138.62 161.07 38.05 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 119.924 1.238 . . . . 72.019999999999996 109.905 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -82.49 151.52 65.52 Favored Pre-proline 0 C--N 1.355 0.833 0 CA-C-O 116.391 -1.766 . . . . 73.230000000000004 108.268 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 C--N 1.361 1.206 0 CA-C-N 122.762 2.022 . . . . 75.340000000000003 108.812 -179.729 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.522 -0.751 . . . . 64.430000000000007 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.7 28.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 118.4 0.545 . . . . 74.120000000000005 110.093 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.78 166.15 12.49 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.124 -1.59 . . . . 74.409999999999997 109.124 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.51 15.19 9.58 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 124.458 0.74 . . . . 72.140000000000001 110.917 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -59.64 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 73.319999999999993 110.881 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.52 62.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 51.450000000000003 112.446 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.2 mt -107.22 99.29 8.84 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 119.105 -2.409 . . . . 71.400000000000006 106.981 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -54.71 150.32 9.78 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 119.627 1.103 . . . . 75.400000000000006 109.729 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -72.21 -50.51 26.96 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 107.5 -1.296 . . . . 75.25 107.5 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.4 p -128.75 160.75 31.55 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 123.91 0.756 . . . . 75.219999999999999 110.137 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -60.41 -38.55 84.37 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 118.235 -0.888 . . . . 74.230000000000004 112.197 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 t -82.53 -52.92 6.39 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.311 0.959 . . . . 73.540000000000006 111.494 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -70.14 169.24 13.96 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 118.733 0.697 . . . . 75.230000000000004 111.414 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -119.66 65.74 0.8 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.518 -1.66 . . . . 73.209999999999994 106.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 t -139.31 161.08 38.32 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 115.646 -2.121 . . . . 75.109999999999999 106.415 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 5' ' ' SER . 20.8 m-85 -132.61 161.29 34.25 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.804 2.093 . . . . 71.129999999999995 110.612 -169.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.45 150.64 70.81 Favored Pre-proline 0 C--N 1.357 0.914 0 CA-C-O 116.322 -1.799 . . . . 73.319999999999993 107.64 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 C--N 1.359 1.123 0 CA-C-N 123.048 2.124 . . . . 74.0 108.584 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.533 -0.746 . . . . 74.140000000000001 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.89 30.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 118.521 0.6 . . . . 70.409999999999997 109.898 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.56 165.74 12.09 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.084 -1.606 . . . . 64.239999999999995 109.084 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.61 15.08 9.51 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 124.435 0.727 . . . . 75.120000000000005 110.875 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 63.350000000000001 110.866 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 8.12 62.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 63.119999999999997 112.465 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.99 99.29 8.75 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 118.843 -2.563 . . . . 73.549999999999997 106.072 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -55.04 148.11 14.42 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 119.8 1.182 . . . . 74.549999999999997 109.279 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.22 -46.75 66.62 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 107.498 -1.297 . . . . 74.340000000000003 107.498 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.9 p -127.12 171.54 11.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.208 0.943 . . . . 61.43 109.932 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -33.73 65.81 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 117.499 -1.239 . . . . 75.340000000000003 111.35 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -90.73 -61.98 1.55 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.366 1.439 . . . . 61.240000000000002 111.476 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -61.48 173.69 0.88 Allowed 'General case' 0 C--N 1.353 0.749 0 CA-C-N 119.265 0.939 . . . . 62.329999999999998 112.767 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -120.3 58.37 0.92 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.375 -0.972 . . . . 72.239999999999995 108.375 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 t -130.5 170.77 13.79 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 116.552 -1.69 . . . . 62.219999999999999 108.079 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.6 m-85 -138.47 160.21 40.11 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 120.131 1.332 . . . . 73.439999999999998 110.206 -172.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -80.61 151.1 71.09 Favored Pre-proline 0 C--N 1.357 0.893 0 CA-C-O 116.194 -1.86 . . . . 75.439999999999998 107.807 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.36 1.144 0 CA-C-N 123.279 2.207 . . . . 72.349999999999994 108.705 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 119.049 -0.501 . . . . 74.510000000000005 111.291 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.71 29.57 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-O 119.184 -0.436 . . . . 72.540000000000006 110.016 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.0 165.18 12.12 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 108.673 -1.771 . . . . 71.540000000000006 108.673 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.63 15.15 10.25 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 124.379 0.693 . . . . 74.430000000000007 110.862 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.61 -172.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 110.834 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.26 7.9 62.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 73.420000000000002 112.541 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.04 98.13 7.48 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 118.627 -2.69 . . . . 73.430000000000007 106.32 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtm-85 -55.6 148.49 15.81 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-N 119.717 1.144 . . . . 72.150000000000006 110.578 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -70.65 -45.12 65.71 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 108.405 -0.961 . . . . 74.310000000000002 108.405 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.5 p -135.5 160.05 39.7 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.841 0.713 . . . . 73.409999999999997 109.849 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -60.2 -38.09 82.27 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.386 -0.816 . . . . 70.209999999999994 111.747 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -82.65 -53.23 6.09 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 119.03 0.832 . . . . 74.049999999999997 112.732 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 t -71.81 175.04 6.09 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-N 119.192 0.905 . . . . 73.329999999999998 111.548 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -119.68 48.55 1.51 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 108.863 -0.791 . . . . 74.200000000000003 108.863 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -120.22 167.49 12.21 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.01 -1.478 . . . . 71.450000000000003 107.01 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' SER . 30.2 m-85 -135.42 161.03 36.59 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 119.748 1.158 . . . . 75.230000000000004 109.048 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -81.65 151.36 68.08 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 116.368 -1.777 . . . . 61.130000000000003 107.968 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--N 1.36 1.175 0 CA-C-N 122.875 2.063 . . . . 64.239999999999995 108.59 179.525 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.656 -0.687 . . . . 72.400000000000006 111.522 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.78 29.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.393 0.542 . . . . 71.230000000000004 110.086 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.23 165.69 12.34 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 108.919 -1.673 . . . . 70.099999999999994 108.919 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -123.16 15.22 9.83 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.487 0.757 . . . . 62.119999999999997 110.865 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.833 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.18 7.61 62.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.786 -0.721 . . . . 70.420000000000002 112.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.05 102.72 11.68 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 118.442 -2.799 . . . . 75.430000000000007 105.625 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm-85 -58.39 149.37 25.0 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 120.24 1.382 . . . . 74.450000000000003 109.055 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.41 -46.45 66.81 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.47 -1.308 . . . . 73.120000000000005 107.47 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.4 p -128.06 169.12 14.41 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.216 0.948 . . . . 75.299999999999997 109.734 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.4 ptp -72.27 -30.05 64.47 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.296 -1.335 . . . . 74.230000000000004 111.918 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -92.44 -65.45 1.0 Allowed 'General case' 0 C--N 1.356 0.89 0 CA-C-N 120.483 1.492 . . . . 70.109999999999999 111.816 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 t -59.64 154.99 16.52 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.722 1.146 . . . . 74.120000000000005 112.419 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -96.82 49.85 1.09 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-O 118.693 -0.67 . . . . 73.340000000000003 112.147 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -121.66 169.92 10.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-O 116.56 -1.686 . . . . 75.439999999999998 109.456 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.2 m-85 -137.55 158.57 44.11 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.945 1.248 . . . . 74.230000000000004 110.519 -172.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -80.38 151.07 71.75 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.124 -1.893 . . . . 75.25 107.843 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.36 1.141 0 CA-C-N 123.215 2.184 . . . . 70.099999999999994 108.473 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.222 -0.372 0 CA-C-O 118.804 -0.617 . . . . 71.510000000000005 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.05 26.27 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 119.003 -0.522 . . . . 74.450000000000003 110.334 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.45 165.5 13.1 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 108.71 -1.756 . . . . 75.349999999999994 108.71 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.81 15.22 10.1 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 124.409 0.711 . . . . 71.409999999999997 110.849 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.4 m -59.69 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 62.140000000000001 110.866 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.17 7.09 62.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 73.299999999999997 112.517 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.1 95.65 5.92 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.575 -1.544 . . . . 74.420000000000002 106.866 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -53.99 147.78 11.86 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 119.828 1.194 . . . . 73.010000000000005 109.549 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.34 -47.3 61.67 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 107.585 -1.265 . . . . 73.140000000000001 107.585 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -127.32 169.4 13.6 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 124.044 0.84 . . . . 74.319999999999993 109.902 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -70.71 -34.98 72.51 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 118.242 -0.885 . . . . 72.140000000000001 111.638 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -86.47 -67.79 0.79 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.332 0.969 . . . . 73.340000000000003 111.387 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 171.24 0.32 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.107 0.78 . . . . 74.239999999999995 113.107 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.42 43.12 2.42 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.563 0.539 . . . . 73.450000000000003 110.909 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -114.98 168.63 9.75 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-O 116.984 -1.484 . . . . 74.25 107.559 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.4 m-85 -135.58 160.48 38.37 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.032 1.287 . . . . 73.430000000000007 109.487 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -81.11 151.09 69.57 Favored Pre-proline 0 C--N 1.356 0.865 0 CA-C-O 116.244 -1.836 . . . . 73.510000000000005 107.742 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.361 1.186 0 CA-C-N 123.02 2.114 . . . . 75.549999999999997 108.52 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.513 -0.454 0 CA-C-O 118.836 -0.602 . . . . 73.420000000000002 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.82 33.47 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 109.863 -0.421 . . . . 73.409999999999997 109.863 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.52 166.09 12.12 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 109.223 -1.551 . . . . 75.430000000000007 109.223 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.27 15.08 9.74 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.325 0.662 . . . . 75.439999999999998 110.827 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.72 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 110.861 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.45 62.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 73.409999999999997 112.477 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.15 105.23 14.87 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 118.462 -2.787 . . . . 74.340000000000003 105.491 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -61.85 149.03 41.42 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.36 1.436 . . . . 75.450000000000003 107.779 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -68.66 -44.51 73.95 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 107.392 -1.336 . . . . 72.219999999999999 107.392 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.5 p -129.47 171.08 12.91 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.049 0.843 . . . . 75.0 109.606 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 mmt -72.23 -36.71 69.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 117.931 -1.033 . . . . 73.310000000000002 110.966 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -86.23 -67.43 0.81 Allowed 'General case' 0 C--N 1.355 0.841 0 CA-C-N 119.864 1.211 . . . . 72.420000000000002 111.893 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 t -61.16 153.08 26.84 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.67 1.123 . . . . 74.450000000000003 111.041 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -103.01 63.83 0.83 Allowed 'General case' 0 C--N 1.358 0.951 0 N-CA-C 109.304 -0.628 . . . . 75.439999999999998 109.304 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -125.71 161.24 27.75 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 116.274 -1.822 . . . . 74.530000000000001 107.053 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.3 m-85 -129.55 160.51 33.03 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.959 1.709 . . . . 74.450000000000003 109.862 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -81.26 151.62 69.72 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-O 116.294 -1.812 . . . . 74.019999999999996 107.953 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.359 1.111 0 CA-C-N 123.05 2.125 . . . . 74.329999999999998 108.886 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 118.783 -0.627 . . . . 73.420000000000002 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.18 28.69 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-O 119.039 -0.505 . . . . 73.349999999999994 110.408 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.47 167.03 12.7 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.978 -1.649 . . . . 64.420000000000002 108.978 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -123.72 15.17 9.43 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.421 0.718 . . . . 74.129999999999995 110.862 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.48 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.66 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 74.299999999999997 110.862 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 7.58 62.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 65.230000000000004 112.503 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.42 101.01 10.4 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 118.008 -3.054 . . . . 73.400000000000006 105.752 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -57.14 148.59 21.62 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.122 1.328 . . . . 73.439999999999998 109.189 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -68.86 -47.67 65.34 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.584 -1.265 . . . . 71.329999999999998 107.584 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -125.83 173.32 9.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.273 0.983 . . . . 72.439999999999998 109.055 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.0 mmt -72.98 -46.69 50.85 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 119.868 -0.733 . . . . 64.340000000000003 109.824 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -73.57 -66.65 0.67 Allowed 'General case' 0 C--N 1.355 0.817 0 CA-C-N 119.042 0.837 . . . . 73.439999999999998 111.813 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -60.47 167.9 2.37 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 119.694 1.134 . . . . 73.200000000000003 112.487 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.96 71.12 0.79 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.296 -1.372 . . . . 74.310000000000002 107.296 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -139.75 169.08 18.39 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.043 -1.932 . . . . 74.109999999999999 107.492 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 5' ' ' SER . 16.4 m-85 -137.62 159.36 42.19 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.886 1.675 . . . . 74.430000000000007 110.651 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -79.83 149.55 70.86 Favored Pre-proline 0 C--N 1.356 0.883 0 CA-C-O 116.222 -1.847 . . . . 74.420000000000002 107.274 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 C--N 1.359 1.127 0 CA-C-N 123.175 2.17 . . . . 74.409999999999997 110.092 179.319 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.408 -0.806 . . . . 72.319999999999993 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.02 27.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 CA-C-N 118.666 0.666 . . . . 71.439999999999998 110.015 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.33 166.13 13.27 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 108.965 -1.654 . . . . 64.310000000000002 108.965 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.38 15.16 9.67 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 124.375 0.691 . . . . 54.210000000000001 110.871 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -59.64 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 74.519999999999996 110.836 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 6.38 61.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 74.150000000000006 112.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.75 107.2 18.09 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 118.797 -2.59 . . . . 74.420000000000002 105.772 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.87 151.11 43.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.437 1.471 . . . . 72.349999999999994 108.629 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -71.11 -44.21 66.1 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.748 1.158 . . . . 74.140000000000001 108.109 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.9 p -135.41 165.16 26.12 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 123.796 0.685 . . . . 72.209999999999994 109.477 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.8 mmt -64.91 -43.49 92.67 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 118.746 -0.645 . . . . 73.450000000000003 109.932 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.1 m -76.99 -50.88 12.15 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 118.572 -0.727 . . . . 75.150000000000006 112.926 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -72.27 174.49 7.19 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 119.29 0.95 . . . . 64.349999999999994 111.968 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.55 42.16 2.34 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 118.626 -0.702 . . . . 74.109999999999999 110.407 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -118.94 168.76 10.49 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 116.984 -1.484 . . . . 75.329999999999998 108.142 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 5' ' ' SER . 29.4 m-85 -137.57 161.55 36.13 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.009 1.277 . . . . 73.099999999999994 109.93 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -81.74 150.46 66.11 Favored Pre-proline 0 C--N 1.356 0.853 0 CA-C-O 116.183 -1.865 . . . . 74.409999999999997 108.012 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.11 2.146 . . . . 73.019999999999996 108.607 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 119.232 -0.414 . . . . 71.420000000000002 111.066 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.84 30.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 0 CA-C-O 119.357 -0.354 . . . . 75.5 110.115 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.87 165.49 12.05 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 108.913 -1.675 . . . . 62.43 108.913 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.409 0.711 . . . . 74.219999999999999 110.831 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.1 m -59.75 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 110.86 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 7.07 61.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 52.5 112.48 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.91 102.54 11.97 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 120.119 -1.812 . . . . 73.099999999999994 107.231 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.25 150.34 26.04 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.948 1.249 . . . . 74.239999999999995 108.965 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.28 -44.89 64.34 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 119.386 0.994 . . . . 75.299999999999997 108.334 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -136.13 161.64 35.15 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.801 0.688 . . . . 74.349999999999994 109.955 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -58.01 -37.26 73.96 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 118.369 -0.824 . . . . 73.430000000000007 111.902 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -87.91 -53.55 4.69 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 118.995 0.816 . . . . 74.030000000000001 112.015 -168.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -71.54 171.34 11.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.473 -0.775 . . . . 75.25 110.521 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -118.17 53.15 0.97 Allowed 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.229 -1.026 . . . . 75.430000000000007 108.229 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -118.19 166.72 12.25 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.166 -1.79 . . . . 72.5 106.166 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.7 m-85 -134.84 160.8 37.06 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 120.039 1.29 . . . . 74.409999999999997 109.27 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -81.0 150.29 68.4 Favored Pre-proline 0 C--N 1.355 0.814 0 CA-C-O 116.426 -1.75 . . . . 75.239999999999995 107.731 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.359 1.131 0 CA-C-N 122.719 2.007 . . . . 71.349999999999994 108.883 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.682 -0.675 . . . . 75.319999999999993 111.444 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.18 30.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 CA-C-N 118.428 0.558 . . . . 65.230000000000004 110.048 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.84 165.1 12.07 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.079 -1.609 . . . . 61.030000000000001 109.079 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.02 15.18 9.93 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.406 0.709 . . . . 74.310000000000002 110.839 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 15.6 m -59.71 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 65.310000000000002 110.85 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.22 6.57 61.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 55.420000000000002 112.467 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.19 101.58 11.06 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.828 -1.984 . . . . 72.329999999999998 106.305 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.23 149.57 23.85 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.181 1.355 . . . . 73.239999999999995 109.811 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -70.47 -43.79 69.08 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.012 -1.107 . . . . 61.509999999999998 108.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -136.53 162.77 32.18 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 123.877 0.736 . . . . 62.409999999999997 109.85 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.4 mmt -61.38 -44.31 97.38 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.916 -0.564 . . . . 74.209999999999994 110.064 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 t -74.15 -52.77 11.5 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 112.966 0.728 . . . . 51.219999999999999 112.966 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -77.2 177.17 8.09 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.085 0.857 . . . . 75.420000000000002 112.62 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -119.14 55.94 0.93 Allowed 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.369 -0.974 . . . . 75.400000000000006 108.369 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 t -129.74 170.76 13.44 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 116.762 -1.59 . . . . 72.510000000000005 108.025 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 5' ' ' SER . 21.8 m-85 -139.63 161.04 38.48 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.916 1.235 . . . . 73.430000000000007 110.273 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -81.55 150.61 67.1 Favored Pre-proline 0 C--N 1.355 0.844 0 CA-C-O 116.522 -1.704 . . . . 73.219999999999999 107.788 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.36 1.14 0 CA-C-N 122.879 2.064 . . . . 72.409999999999997 110.019 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 118.69 -0.671 . . . . 74.25 111.67 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.42 30.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 CA-C-N 118.365 0.53 . . . . 75.239999999999995 109.901 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.76 164.95 12.01 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 109.023 -1.631 . . . . 72.209999999999994 109.023 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.01 15.27 9.94 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.375 0.691 . . . . 71.129999999999995 110.888 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.452 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.76 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.329999999999998 110.842 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 6.92 61.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 71.519999999999996 112.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.76 107.15 18.02 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 117.646 -3.267 . . . . 74.430000000000007 106.929 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.67 152.57 26.21 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.166 1.348 . . . . 75.409999999999997 109.038 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -71.81 -43.92 64.79 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.297 -1.001 . . . . 73.340000000000003 108.297 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.8 p -137.0 161.42 36.09 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 123.733 0.646 . . . . 72.239999999999995 109.925 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -36.49 84.13 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 118.433 -0.794 . . . . 63.450000000000003 111.517 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 t -80.48 -50.35 10.18 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 119.215 0.916 . . . . 75.310000000000002 112.182 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -72.54 -173.82 1.24 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.753 0.706 . . . . 75.400000000000006 111.505 -170.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.63 49.83 2.21 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.594 -0.891 . . . . 75.310000000000002 108.594 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -126.2 162.04 26.34 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 116.425 -1.75 . . . . 71.439999999999998 106.329 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.9 m-85 -130.57 161.59 31.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 120.831 1.65 . . . . 72.010000000000005 109.847 -172.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -79.65 151.0 73.8 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 116.122 -1.894 . . . . 73.340000000000003 107.577 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.359 1.092 0 CA-C-N 123.338 2.228 . . . . 72.099999999999994 108.641 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 119.216 -0.421 . . . . 73.5 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.36 31.73 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.818 -0.438 . . . . 74.409999999999997 109.818 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.27 166.0 12.1 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 108.73 -1.748 . . . . 52.200000000000003 108.73 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.68 14.89 9.44 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.371 0.689 . . . . 73.409999999999997 110.843 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 3.6 t -59.84 -171.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 110.841 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.63 6.81 59.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.319999999999993 112.509 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.98 110.68 22.93 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 119.68 -2.07 . . . . 73.209999999999994 105.608 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.76 151.26 47.02 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.465 1.484 . . . . 74.140000000000001 107.125 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -71.18 -52.22 20.42 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.521 -1.289 . . . . 74.439999999999998 107.521 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 p -126.17 162.63 24.95 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.001 0.813 . . . . 75.129999999999995 109.623 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -67.53 -32.93 74.06 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.373 -0.822 . . . . 71.510000000000005 111.874 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -83.36 -47.61 11.27 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.144 0.884 . . . . 71.120000000000005 112.584 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -75.26 -173.77 2.14 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 118.878 0.763 . . . . 74.109999999999999 111.571 -171.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.17 45.38 2.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.328 -0.619 . . . . 72.129999999999995 109.328 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -117.47 171.65 7.85 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 106.317 -1.734 . . . . 74.040000000000006 106.317 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.2 m-85 -137.96 162.02 35.16 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 120.101 1.319 . . . . 73.319999999999993 109.554 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.32 150.82 64.82 Favored Pre-proline 0 C--N 1.355 0.845 0 CA-C-O 116.485 -1.721 . . . . 71.540000000000006 108.048 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.36 1.134 0 CA-C-N 122.708 2.003 . . . . 74.219999999999999 108.835 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 CA--C 1.514 -0.414 0 CA-C-O 118.868 -0.587 . . . . 74.530000000000001 110.825 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.05 30.16 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.783 -0.451 . . . . 73.049999999999997 109.783 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.98 165.31 12.15 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 108.849 -1.7 . . . . 72.530000000000001 108.849 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.82 14.72 10.05 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 124.448 0.734 . . . . 73.099999999999994 110.894 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.495 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.8 -171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.831 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.73 59.1 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 70.450000000000003 112.475 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.94 114.98 29.62 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 117.41 -3.406 . . . . 74.150000000000006 105.243 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -66.84 150.84 48.59 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.984 1.72 . . . . 73.030000000000001 106.749 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.8 -50.91 38.4 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.4 -1.333 . . . . 62.43 107.4 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 p -128.59 162.13 28.01 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 123.946 0.779 . . . . 72.109999999999999 110.075 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -61.63 -39.15 90.26 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.265 -0.874 . . . . 72.319999999999993 111.897 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -83.45 -51.71 7.14 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 119.201 0.91 . . . . 72.140000000000001 111.895 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 t -70.0 175.45 4.43 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.944 0.793 . . . . 74.340000000000003 110.713 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -127.14 49.67 2.06 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.11 -1.07 . . . . 74.349999999999994 108.11 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -118.16 173.55 6.73 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.468 -1.678 . . . . 72.310000000000002 106.468 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.2 m-85 -138.59 161.24 37.59 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.746 1.612 . . . . 74.439999999999998 109.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -82.1 151.33 66.5 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.217 -1.849 . . . . 74.439999999999998 108.069 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.104 2.144 . . . . 71.230000000000004 108.646 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.834 -0.603 . . . . 72.439999999999998 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.63 31.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.848 -0.427 . . . . 73.25 109.848 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.44 166.94 12.32 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 108.935 -1.666 . . . . 75.450000000000003 108.935 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.0 14.8 9.2 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 124.432 0.724 . . . . 73.439999999999998 110.839 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.2 t -59.83 -172.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.873 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.33 58.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.761 . . . . 71.310000000000002 112.465 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.69 115.85 31.24 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 118.535 -2.744 . . . . 74.230000000000004 105.599 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.21 150.22 48.57 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.862 1.664 . . . . 75.219999999999999 106.74 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.26 -45.99 65.29 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 119.905 1.23 . . . . 71.349999999999994 108.312 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -130.37 167.15 19.01 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.008 0.817 . . . . 74.549999999999997 109.145 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.4 mmt -69.13 -38.56 78.92 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 118.374 -0.822 . . . . 73.310000000000002 110.42 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 t -82.86 -52.76 6.43 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.132 0.878 . . . . 74.010000000000005 112.524 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -70.67 177.19 3.65 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 119.51 1.05 . . . . 65.140000000000001 112.028 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 pm0 -121.2 49.01 1.55 Allowed 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.246 -0.65 . . . . 75.319999999999993 109.246 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -118.67 171.03 8.47 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 116.899 -1.524 . . . . 61.420000000000002 107.884 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 5' ' ' SER . 19.1 m-85 -139.28 160.18 40.43 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.038 1.29 . . . . 71.420000000000002 110.238 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -81.96 151.06 66.59 Favored Pre-proline 0 C--N 1.356 0.884 0 CA-C-O 116.358 -1.782 . . . . 75.439999999999998 108.151 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 C--N 1.36 1.174 0 CA-C-N 122.793 2.033 . . . . 74.109999999999999 110.133 179.241 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 118.875 -0.583 . . . . 72.420000000000002 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.75 33.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.696 -0.483 . . . . 72.109999999999999 109.696 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.65 12.18 Favored Glycine 0 C--N 1.354 1.537 0 N-CA-C 109.047 -1.621 . . . . 72.040000000000006 109.047 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.69 15.14 9.45 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 124.397 0.704 . . . . 70.209999999999994 110.823 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -59.67 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.530000000000001 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.27 6.2 61.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.299999999999997 112.49 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.49 102.72 12.17 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 119.203 -2.351 . . . . 74.439999999999998 106.09 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -57.48 150.42 18.8 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.099 1.318 . . . . 72.0 109.438 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -71.44 -51.32 24.5 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 107.36 -1.348 . . . . 73.209999999999994 107.36 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 p -125.72 162.77 24.3 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.045 0.841 . . . . 74.310000000000002 109.829 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -64.68 -35.42 80.97 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.375 -0.821 . . . . 73.109999999999999 111.788 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -85.74 -51.2 6.59 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 119.074 0.852 . . . . 74.120000000000005 112.298 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -72.89 176.82 5.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.098 0.863 . . . . 72.140000000000001 111.811 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 52.44 1.25 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.728 -0.842 . . . . 75.319999999999993 108.728 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 t -122.91 170.51 10.05 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 116.799 -1.572 . . . . 75.140000000000001 107.499 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 5' ' ' SER . 23.9 m-85 -138.62 161.07 38.05 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 119.924 1.238 . . . . 72.019999999999996 109.905 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -82.49 151.52 65.52 Favored Pre-proline 0 C--N 1.355 0.833 0 CA-C-O 116.391 -1.766 . . . . 73.230000000000004 108.268 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 C--N 1.361 1.206 0 CA-C-N 122.762 2.022 . . . . 75.340000000000003 108.812 -179.729 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.522 -0.751 . . . . 64.430000000000007 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.7 28.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 118.4 0.545 . . . . 74.120000000000005 110.093 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.78 166.15 12.49 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.124 -1.59 . . . . 74.409999999999997 109.124 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.51 15.19 9.58 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 124.458 0.74 . . . . 72.140000000000001 110.917 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -59.64 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 73.319999999999993 110.881 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.52 62.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 51.450000000000003 112.446 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.2 mt -107.22 99.29 8.84 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 119.105 -2.409 . . . . 71.400000000000006 106.981 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -54.71 150.32 9.78 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 119.627 1.103 . . . . 75.400000000000006 109.729 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -72.21 -50.51 26.96 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 107.5 -1.296 . . . . 75.25 107.5 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.4 p -128.75 160.75 31.55 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 123.91 0.756 . . . . 75.219999999999999 110.137 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -60.41 -38.55 84.37 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 118.235 -0.888 . . . . 74.230000000000004 112.197 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 t -82.53 -52.92 6.39 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.311 0.959 . . . . 73.540000000000006 111.494 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -70.14 169.24 13.96 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 118.733 0.697 . . . . 75.230000000000004 111.414 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -119.66 65.74 0.8 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.518 -1.66 . . . . 73.209999999999994 106.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 t -139.31 161.08 38.32 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 115.646 -2.121 . . . . 75.109999999999999 106.415 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 5' ' ' SER . 20.8 m-85 -132.61 161.29 34.25 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.804 2.093 . . . . 71.129999999999995 110.612 -169.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.45 150.64 70.81 Favored Pre-proline 0 C--N 1.357 0.914 0 CA-C-O 116.322 -1.799 . . . . 73.319999999999993 107.64 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 C--N 1.359 1.123 0 CA-C-N 123.048 2.124 . . . . 74.0 108.584 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.533 -0.746 . . . . 74.140000000000001 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.89 30.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 118.521 0.6 . . . . 70.409999999999997 109.898 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.56 165.74 12.09 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.084 -1.606 . . . . 64.239999999999995 109.084 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.61 15.08 9.51 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 124.435 0.727 . . . . 75.120000000000005 110.875 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 63.350000000000001 110.866 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 8.12 62.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 63.119999999999997 112.465 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.99 99.29 8.75 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 118.843 -2.563 . . . . 73.549999999999997 106.072 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -55.04 148.11 14.42 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 119.8 1.182 . . . . 74.549999999999997 109.279 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.22 -46.75 66.62 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 107.498 -1.297 . . . . 74.340000000000003 107.498 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.9 p -127.12 171.54 11.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.208 0.943 . . . . 61.43 109.932 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -33.73 65.81 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 117.499 -1.239 . . . . 75.340000000000003 111.35 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -90.73 -61.98 1.55 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.366 1.439 . . . . 61.240000000000002 111.476 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -61.48 173.69 0.88 Allowed 'General case' 0 C--N 1.353 0.749 0 CA-C-N 119.265 0.939 . . . . 62.329999999999998 112.767 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -120.3 58.37 0.92 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.375 -0.972 . . . . 72.239999999999995 108.375 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 t -130.5 170.77 13.79 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 116.552 -1.69 . . . . 62.219999999999999 108.079 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.6 m-85 -138.47 160.21 40.11 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 120.131 1.332 . . . . 73.439999999999998 110.206 -172.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -80.61 151.1 71.09 Favored Pre-proline 0 C--N 1.357 0.893 0 CA-C-O 116.194 -1.86 . . . . 75.439999999999998 107.807 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.36 1.144 0 CA-C-N 123.279 2.207 . . . . 72.349999999999994 108.705 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 119.049 -0.501 . . . . 74.510000000000005 111.291 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.71 29.57 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-O 119.184 -0.436 . . . . 72.540000000000006 110.016 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.0 165.18 12.12 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 108.673 -1.771 . . . . 71.540000000000006 108.673 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.63 15.15 10.25 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 124.379 0.693 . . . . 74.430000000000007 110.862 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.61 -172.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 110.834 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.26 7.9 62.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 73.420000000000002 112.541 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.04 98.13 7.48 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 118.627 -2.69 . . . . 73.430000000000007 106.32 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtm-85 -55.6 148.49 15.81 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-N 119.717 1.144 . . . . 72.150000000000006 110.578 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -70.65 -45.12 65.71 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 108.405 -0.961 . . . . 74.310000000000002 108.405 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.5 p -135.5 160.05 39.7 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.841 0.713 . . . . 73.409999999999997 109.849 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -60.2 -38.09 82.27 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.386 -0.816 . . . . 70.209999999999994 111.747 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -82.65 -53.23 6.09 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 119.03 0.832 . . . . 74.049999999999997 112.732 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 t -71.81 175.04 6.09 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-N 119.192 0.905 . . . . 73.329999999999998 111.548 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -119.68 48.55 1.51 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 108.863 -0.791 . . . . 74.200000000000003 108.863 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -120.22 167.49 12.21 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.01 -1.478 . . . . 71.450000000000003 107.01 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' SER . 30.2 m-85 -135.42 161.03 36.59 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 119.748 1.158 . . . . 75.230000000000004 109.048 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -81.65 151.36 68.08 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 116.368 -1.777 . . . . 61.130000000000003 107.968 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--N 1.36 1.175 0 CA-C-N 122.875 2.063 . . . . 64.239999999999995 108.59 179.525 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.656 -0.687 . . . . 72.400000000000006 111.522 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.78 29.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.393 0.542 . . . . 71.230000000000004 110.086 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.23 165.69 12.34 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 108.919 -1.673 . . . . 70.099999999999994 108.919 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -123.16 15.22 9.83 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.487 0.757 . . . . 62.119999999999997 110.865 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.833 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.18 7.61 62.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.786 -0.721 . . . . 70.420000000000002 112.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.05 102.72 11.68 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 118.442 -2.799 . . . . 75.430000000000007 105.625 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm-85 -58.39 149.37 25.0 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 120.24 1.382 . . . . 74.450000000000003 109.055 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.41 -46.45 66.81 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.47 -1.308 . . . . 73.120000000000005 107.47 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.4 p -128.06 169.12 14.41 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.216 0.948 . . . . 75.299999999999997 109.734 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.4 ptp -72.27 -30.05 64.47 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.296 -1.335 . . . . 74.230000000000004 111.918 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -92.44 -65.45 1.0 Allowed 'General case' 0 C--N 1.356 0.89 0 CA-C-N 120.483 1.492 . . . . 70.109999999999999 111.816 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 t -59.64 154.99 16.52 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.722 1.146 . . . . 74.120000000000005 112.419 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -96.82 49.85 1.09 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-O 118.693 -0.67 . . . . 73.340000000000003 112.147 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -121.66 169.92 10.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-O 116.56 -1.686 . . . . 75.439999999999998 109.456 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.2 m-85 -137.55 158.57 44.11 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.945 1.248 . . . . 74.230000000000004 110.519 -172.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -80.38 151.07 71.75 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.124 -1.893 . . . . 75.25 107.843 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.36 1.141 0 CA-C-N 123.215 2.184 . . . . 70.099999999999994 108.473 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.222 -0.372 0 CA-C-O 118.804 -0.617 . . . . 71.510000000000005 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.05 26.27 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 119.003 -0.522 . . . . 74.450000000000003 110.334 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.45 165.5 13.1 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 108.71 -1.756 . . . . 75.349999999999994 108.71 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.81 15.22 10.1 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 124.409 0.711 . . . . 71.409999999999997 110.849 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.4 m -59.69 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 62.140000000000001 110.866 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.17 7.09 62.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 73.299999999999997 112.517 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.1 95.65 5.92 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.575 -1.544 . . . . 74.420000000000002 106.866 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -53.99 147.78 11.86 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 119.828 1.194 . . . . 73.010000000000005 109.549 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.34 -47.3 61.67 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 107.585 -1.265 . . . . 73.140000000000001 107.585 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -127.32 169.4 13.6 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 124.044 0.84 . . . . 74.319999999999993 109.902 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -70.71 -34.98 72.51 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 118.242 -0.885 . . . . 72.140000000000001 111.638 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -86.47 -67.79 0.79 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.332 0.969 . . . . 73.340000000000003 111.387 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 171.24 0.32 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.107 0.78 . . . . 74.239999999999995 113.107 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.42 43.12 2.42 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.563 0.539 . . . . 73.450000000000003 110.909 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -114.98 168.63 9.75 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-O 116.984 -1.484 . . . . 74.25 107.559 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.4 m-85 -135.58 160.48 38.37 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.032 1.287 . . . . 73.430000000000007 109.487 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -81.11 151.09 69.57 Favored Pre-proline 0 C--N 1.356 0.865 0 CA-C-O 116.244 -1.836 . . . . 73.510000000000005 107.742 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.361 1.186 0 CA-C-N 123.02 2.114 . . . . 75.549999999999997 108.52 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.513 -0.454 0 CA-C-O 118.836 -0.602 . . . . 73.420000000000002 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.82 33.47 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 109.863 -0.421 . . . . 73.409999999999997 109.863 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.52 166.09 12.12 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 109.223 -1.551 . . . . 75.430000000000007 109.223 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.27 15.08 9.74 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.325 0.662 . . . . 75.439999999999998 110.827 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.72 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 110.861 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.45 62.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 73.409999999999997 112.477 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.15 105.23 14.87 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 118.462 -2.787 . . . . 74.340000000000003 105.491 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -61.85 149.03 41.42 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.36 1.436 . . . . 75.450000000000003 107.779 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -68.66 -44.51 73.95 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 107.392 -1.336 . . . . 72.219999999999999 107.392 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.5 p -129.47 171.08 12.91 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.049 0.843 . . . . 75.0 109.606 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 mmt -72.23 -36.71 69.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 117.931 -1.033 . . . . 73.310000000000002 110.966 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -86.23 -67.43 0.81 Allowed 'General case' 0 C--N 1.355 0.841 0 CA-C-N 119.864 1.211 . . . . 72.420000000000002 111.893 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 t -61.16 153.08 26.84 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.67 1.123 . . . . 74.450000000000003 111.041 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -103.01 63.83 0.83 Allowed 'General case' 0 C--N 1.358 0.951 0 N-CA-C 109.304 -0.628 . . . . 75.439999999999998 109.304 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -125.71 161.24 27.75 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 116.274 -1.822 . . . . 74.530000000000001 107.053 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.3 m-85 -129.55 160.51 33.03 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.959 1.709 . . . . 74.450000000000003 109.862 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -81.26 151.62 69.72 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-O 116.294 -1.812 . . . . 74.019999999999996 107.953 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.359 1.111 0 CA-C-N 123.05 2.125 . . . . 74.329999999999998 108.886 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 118.783 -0.627 . . . . 73.420000000000002 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.18 28.69 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-O 119.039 -0.505 . . . . 73.349999999999994 110.408 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.47 167.03 12.7 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.978 -1.649 . . . . 64.420000000000002 108.978 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -123.72 15.17 9.43 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.421 0.718 . . . . 74.129999999999995 110.862 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.48 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.66 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 74.299999999999997 110.862 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 7.58 62.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 65.230000000000004 112.503 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.42 101.01 10.4 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 118.008 -3.054 . . . . 73.400000000000006 105.752 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -57.14 148.59 21.62 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.122 1.328 . . . . 73.439999999999998 109.189 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -68.86 -47.67 65.34 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.584 -1.265 . . . . 71.329999999999998 107.584 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -125.83 173.32 9.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.273 0.983 . . . . 72.439999999999998 109.055 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.0 mmt -72.98 -46.69 50.85 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 119.868 -0.733 . . . . 64.340000000000003 109.824 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -73.57 -66.65 0.67 Allowed 'General case' 0 C--N 1.355 0.817 0 CA-C-N 119.042 0.837 . . . . 73.439999999999998 111.813 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -60.47 167.9 2.37 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 119.694 1.134 . . . . 73.200000000000003 112.487 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.96 71.12 0.79 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.296 -1.372 . . . . 74.310000000000002 107.296 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -139.75 169.08 18.39 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.043 -1.932 . . . . 74.109999999999999 107.492 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 5' ' ' SER . 16.4 m-85 -137.62 159.36 42.19 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.886 1.675 . . . . 74.430000000000007 110.651 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -79.83 149.55 70.86 Favored Pre-proline 0 C--N 1.356 0.883 0 CA-C-O 116.222 -1.847 . . . . 74.420000000000002 107.274 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 C--N 1.359 1.127 0 CA-C-N 123.175 2.17 . . . . 74.409999999999997 110.092 179.319 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.408 -0.806 . . . . 72.319999999999993 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.02 27.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 CA-C-N 118.666 0.666 . . . . 71.439999999999998 110.015 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.33 166.13 13.27 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 108.965 -1.654 . . . . 64.310000000000002 108.965 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.38 15.16 9.67 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 124.375 0.691 . . . . 54.210000000000001 110.871 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -59.64 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 74.519999999999996 110.836 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 6.38 61.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 74.150000000000006 112.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.75 107.2 18.09 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 118.797 -2.59 . . . . 74.420000000000002 105.772 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.87 151.11 43.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.437 1.471 . . . . 72.349999999999994 108.629 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -71.11 -44.21 66.1 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.748 1.158 . . . . 74.140000000000001 108.109 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.9 p -135.41 165.16 26.12 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 123.796 0.685 . . . . 72.209999999999994 109.477 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.8 mmt -64.91 -43.49 92.67 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 118.746 -0.645 . . . . 73.450000000000003 109.932 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.1 m -76.99 -50.88 12.15 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 118.572 -0.727 . . . . 75.150000000000006 112.926 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -72.27 174.49 7.19 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 119.29 0.95 . . . . 64.349999999999994 111.968 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.55 42.16 2.34 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 118.626 -0.702 . . . . 74.109999999999999 110.407 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -118.94 168.76 10.49 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 116.984 -1.484 . . . . 75.329999999999998 108.142 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 5' ' ' SER . 29.4 m-85 -137.57 161.55 36.13 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.009 1.277 . . . . 73.099999999999994 109.93 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -81.74 150.46 66.11 Favored Pre-proline 0 C--N 1.356 0.853 0 CA-C-O 116.183 -1.865 . . . . 74.409999999999997 108.012 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.11 2.146 . . . . 73.019999999999996 108.607 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 119.232 -0.414 . . . . 71.420000000000002 111.066 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.84 30.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 0 CA-C-O 119.357 -0.354 . . . . 75.5 110.115 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.87 165.49 12.05 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 108.913 -1.675 . . . . 62.43 108.913 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.409 0.711 . . . . 74.219999999999999 110.831 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.1 m -59.75 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 110.86 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 7.07 61.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 52.5 112.48 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.91 102.54 11.97 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 120.119 -1.812 . . . . 73.099999999999994 107.231 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.25 150.34 26.04 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.948 1.249 . . . . 74.239999999999995 108.965 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.28 -44.89 64.34 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 119.386 0.994 . . . . 75.299999999999997 108.334 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -136.13 161.64 35.15 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.801 0.688 . . . . 74.349999999999994 109.955 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -58.01 -37.26 73.96 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 118.369 -0.824 . . . . 73.430000000000007 111.902 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -87.91 -53.55 4.69 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 118.995 0.816 . . . . 74.030000000000001 112.015 -168.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -71.54 171.34 11.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.473 -0.775 . . . . 75.25 110.521 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -118.17 53.15 0.97 Allowed 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.229 -1.026 . . . . 75.430000000000007 108.229 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -118.19 166.72 12.25 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.166 -1.79 . . . . 72.5 106.166 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.7 m-85 -134.84 160.8 37.06 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 120.039 1.29 . . . . 74.409999999999997 109.27 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -81.0 150.29 68.4 Favored Pre-proline 0 C--N 1.355 0.814 0 CA-C-O 116.426 -1.75 . . . . 75.239999999999995 107.731 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.359 1.131 0 CA-C-N 122.719 2.007 . . . . 71.349999999999994 108.883 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.682 -0.675 . . . . 75.319999999999993 111.444 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.18 30.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 CA-C-N 118.428 0.558 . . . . 65.230000000000004 110.048 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.84 165.1 12.07 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.079 -1.609 . . . . 61.030000000000001 109.079 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.02 15.18 9.93 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.406 0.709 . . . . 74.310000000000002 110.839 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 15.6 m -59.71 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 65.310000000000002 110.85 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.22 6.57 61.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 55.420000000000002 112.467 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.19 101.58 11.06 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.828 -1.984 . . . . 72.329999999999998 106.305 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.23 149.57 23.85 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.181 1.355 . . . . 73.239999999999995 109.811 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -70.47 -43.79 69.08 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.012 -1.107 . . . . 61.509999999999998 108.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -136.53 162.77 32.18 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 123.877 0.736 . . . . 62.409999999999997 109.85 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.4 mmt -61.38 -44.31 97.38 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.916 -0.564 . . . . 74.209999999999994 110.064 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 t -74.15 -52.77 11.5 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 112.966 0.728 . . . . 51.219999999999999 112.966 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -77.2 177.17 8.09 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.085 0.857 . . . . 75.420000000000002 112.62 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -119.14 55.94 0.93 Allowed 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.369 -0.974 . . . . 75.400000000000006 108.369 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 t -129.74 170.76 13.44 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 116.762 -1.59 . . . . 72.510000000000005 108.025 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 5' ' ' SER . 21.8 m-85 -139.63 161.04 38.48 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.916 1.235 . . . . 73.430000000000007 110.273 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -81.55 150.61 67.1 Favored Pre-proline 0 C--N 1.355 0.844 0 CA-C-O 116.522 -1.704 . . . . 73.219999999999999 107.788 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.36 1.14 0 CA-C-N 122.879 2.064 . . . . 72.409999999999997 110.019 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 118.69 -0.671 . . . . 74.25 111.67 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.42 30.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 CA-C-N 118.365 0.53 . . . . 75.239999999999995 109.901 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.76 164.95 12.01 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 109.023 -1.631 . . . . 72.209999999999994 109.023 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.01 15.27 9.94 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.375 0.691 . . . . 71.129999999999995 110.888 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.452 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.76 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.329999999999998 110.842 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 6.92 61.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 71.519999999999996 112.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.76 107.15 18.02 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 117.646 -3.267 . . . . 74.430000000000007 106.929 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.67 152.57 26.21 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.166 1.348 . . . . 75.409999999999997 109.038 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -71.81 -43.92 64.79 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.297 -1.001 . . . . 73.340000000000003 108.297 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.8 p -137.0 161.42 36.09 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 123.733 0.646 . . . . 72.239999999999995 109.925 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -36.49 84.13 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 118.433 -0.794 . . . . 63.450000000000003 111.517 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 t -80.48 -50.35 10.18 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 119.215 0.916 . . . . 75.310000000000002 112.182 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -72.54 -173.82 1.24 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.753 0.706 . . . . 75.400000000000006 111.505 -170.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.63 49.83 2.21 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.594 -0.891 . . . . 75.310000000000002 108.594 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -126.2 162.04 26.34 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 116.425 -1.75 . . . . 71.439999999999998 106.329 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.9 m-85 -130.57 161.59 31.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 120.831 1.65 . . . . 72.010000000000005 109.847 -172.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -79.65 151.0 73.8 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 116.122 -1.894 . . . . 73.340000000000003 107.577 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.359 1.092 0 CA-C-N 123.338 2.228 . . . . 72.099999999999994 108.641 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 119.216 -0.421 . . . . 73.5 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.36 31.73 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.818 -0.438 . . . . 74.409999999999997 109.818 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.27 166.0 12.1 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 108.73 -1.748 . . . . 52.200000000000003 108.73 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.68 14.89 9.44 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.371 0.689 . . . . 73.409999999999997 110.843 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 3.6 t -59.84 -171.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 110.841 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.63 6.81 59.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.319999999999993 112.509 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.98 110.68 22.93 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 119.68 -2.07 . . . . 73.209999999999994 105.608 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.76 151.26 47.02 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.465 1.484 . . . . 74.140000000000001 107.125 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -71.18 -52.22 20.42 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.521 -1.289 . . . . 74.439999999999998 107.521 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 p -126.17 162.63 24.95 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.001 0.813 . . . . 75.129999999999995 109.623 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -67.53 -32.93 74.06 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.373 -0.822 . . . . 71.510000000000005 111.874 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -83.36 -47.61 11.27 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.144 0.884 . . . . 71.120000000000005 112.584 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -75.26 -173.77 2.14 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 118.878 0.763 . . . . 74.109999999999999 111.571 -171.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.17 45.38 2.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.328 -0.619 . . . . 72.129999999999995 109.328 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -117.47 171.65 7.85 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 106.317 -1.734 . . . . 74.040000000000006 106.317 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.2 m-85 -137.96 162.02 35.16 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 120.101 1.319 . . . . 73.319999999999993 109.554 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.32 150.82 64.82 Favored Pre-proline 0 C--N 1.355 0.845 0 CA-C-O 116.485 -1.721 . . . . 71.540000000000006 108.048 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.36 1.134 0 CA-C-N 122.708 2.003 . . . . 74.219999999999999 108.835 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 CA--C 1.514 -0.414 0 CA-C-O 118.868 -0.587 . . . . 74.530000000000001 110.825 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.05 30.16 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.783 -0.451 . . . . 73.049999999999997 109.783 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.98 165.31 12.15 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 108.849 -1.7 . . . . 72.530000000000001 108.849 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.82 14.72 10.05 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 124.448 0.734 . . . . 73.099999999999994 110.894 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.495 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.8 -171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.831 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.73 59.1 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 70.450000000000003 112.475 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.94 114.98 29.62 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 117.41 -3.406 . . . . 74.150000000000006 105.243 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -66.84 150.84 48.59 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.984 1.72 . . . . 73.030000000000001 106.749 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.8 -50.91 38.4 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.4 -1.333 . . . . 62.43 107.4 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 p -128.59 162.13 28.01 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 123.946 0.779 . . . . 72.109999999999999 110.075 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -61.63 -39.15 90.26 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.265 -0.874 . . . . 72.319999999999993 111.897 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -83.45 -51.71 7.14 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 119.201 0.91 . . . . 72.140000000000001 111.895 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 t -70.0 175.45 4.43 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.944 0.793 . . . . 74.340000000000003 110.713 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -127.14 49.67 2.06 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.11 -1.07 . . . . 74.349999999999994 108.11 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -118.16 173.55 6.73 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.468 -1.678 . . . . 72.310000000000002 106.468 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.2 m-85 -138.59 161.24 37.59 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.746 1.612 . . . . 74.439999999999998 109.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -82.1 151.33 66.5 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.217 -1.849 . . . . 74.439999999999998 108.069 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.104 2.144 . . . . 71.230000000000004 108.646 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.834 -0.603 . . . . 72.44 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.63 31.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.848 -0.427 . . . . 62.55 109.848 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.44 166.94 12.32 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 108.935 -1.666 . . . . 75.45 108.935 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.0 14.8 9.2 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 124.432 0.724 . . . . 73.44 110.839 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.2 t -59.83 -172.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.873 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.33 58.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.761 . . . . 62.52 112.465 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.69 115.85 31.24 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 118.535 -2.744 . . . . 74.23 105.599 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.21 150.22 48.57 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.862 1.664 . . . . 74.31 106.74 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.26 -45.99 65.29 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 119.905 1.23 . . . . 71.35 108.312 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -130.37 167.15 19.01 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.008 0.817 . . . . 74.55 109.145 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.4 mmt -69.13 -38.56 78.92 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 118.374 -0.822 . . . . 52.22 110.42 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 t -82.86 -52.76 6.43 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.132 0.878 . . . . 44.13 112.524 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -70.67 177.19 3.65 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 119.51 1.05 . . . . 63.02 112.028 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 pm0 -121.2 49.01 1.55 Allowed 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.246 -0.65 . . . . 75.32 109.246 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -118.67 171.03 8.47 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 116.899 -1.524 . . . . 54.42 107.884 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 5' ' ' SER . 19.1 m-85 -139.28 160.18 40.43 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.038 1.29 . . . . 71.42 110.238 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -81.96 151.06 66.59 Favored Pre-proline 0 C--N 1.356 0.884 0 CA-C-O 116.358 -1.782 . . . . 72.34 108.151 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 C--N 1.36 1.174 0 CA-C-N 122.793 2.033 . . . . 74.11 110.133 179.241 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 118.875 -0.583 . . . . 72.2 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.75 33.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.696 -0.483 . . . . 62.53 109.696 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.65 12.18 Favored Glycine 0 C--N 1.354 1.537 0 N-CA-C 109.047 -1.621 . . . . 72.04 109.047 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.69 15.14 9.45 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 124.397 0.704 . . . . 65.13 110.823 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -59.67 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 54.42 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.27 6.2 61.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.3 112.49 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.49 102.72 12.17 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 119.203 -2.351 . . . . 54.21 106.09 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -57.48 150.42 18.8 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.099 1.318 . . . . 72.0 109.438 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -71.44 -51.32 24.5 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 107.36 -1.348 . . . . 73.21 107.36 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 p -125.72 162.77 24.3 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.045 0.841 . . . . 74.31 109.829 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -64.68 -35.42 80.97 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.375 -0.821 . . . . 73.11 111.788 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -85.74 -51.2 6.59 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 119.074 0.852 . . . . 73.14 112.298 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -72.89 176.82 5.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.098 0.863 . . . . 71.44 111.811 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 52.44 1.25 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.728 -0.842 . . . . 71.15 108.728 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 t -122.91 170.51 10.05 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 116.799 -1.572 . . . . 75.13 107.499 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 5' ' ' SER . 23.9 m-85 -138.62 161.07 38.05 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 119.924 1.238 . . . . 71.04 109.905 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -82.49 151.52 65.52 Favored Pre-proline 0 C--N 1.355 0.833 0 CA-C-O 116.391 -1.766 . . . . 72.04 108.268 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 C--N 1.361 1.206 0 CA-C-N 122.762 2.022 . . . . 75.34 108.812 -179.729 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.522 -0.751 . . . . 34.31 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.7 28.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 118.4 0.545 . . . . 53.14 110.093 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.78 166.15 12.49 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.124 -1.59 . . . . 71.02 109.124 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.51 15.19 9.58 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 124.458 0.74 . . . . 64.13 110.917 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -59.64 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.881 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.52 62.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 51.45 112.446 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.2 mt -107.22 99.29 8.84 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 119.105 -2.409 . . . . 71.05 106.981 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -54.71 150.32 9.78 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 119.627 1.103 . . . . 75.4 109.729 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -72.21 -50.51 26.96 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 107.5 -1.296 . . . . 75.25 107.5 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.4 p -128.75 160.75 31.55 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 123.91 0.756 . . . . 65.23 110.137 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -60.41 -38.55 84.37 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 118.235 -0.888 . . . . 73.3 112.197 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 t -82.53 -52.92 6.39 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.311 0.959 . . . . 63.43 111.494 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -70.14 169.24 13.96 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 118.733 0.697 . . . . 70.04 111.414 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -119.66 65.74 0.8 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.518 -1.66 . . . . 33.35 106.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 t -139.31 161.08 38.32 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 115.646 -2.121 . . . . 74.24 106.415 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 5' ' ' SER . 20.8 m-85 -132.61 161.29 34.25 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.804 2.093 . . . . 71.13 110.612 -169.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.45 150.64 70.81 Favored Pre-proline 0 C--N 1.357 0.914 0 CA-C-O 116.322 -1.799 . . . . 73.32 107.64 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 C--N 1.359 1.123 0 CA-C-N 123.048 2.124 . . . . 74.0 108.584 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.533 -0.746 . . . . 35.1 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.89 30.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 118.521 0.6 . . . . 52.55 109.898 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.56 165.74 12.09 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.084 -1.606 . . . . 51.14 109.084 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.61 15.08 9.51 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 124.435 0.727 . . . . 75.12 110.875 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.44 110.866 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 8.12 62.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 63.12 112.465 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.99 99.29 8.75 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 118.843 -2.563 . . . . 73.55 106.072 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -55.04 148.11 14.42 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 119.8 1.182 . . . . 72.11 109.279 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.22 -46.75 66.62 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 107.498 -1.297 . . . . 74.14 107.498 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.9 p -127.12 171.54 11.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.208 0.943 . . . . 61.35 109.932 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -33.73 65.81 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 117.499 -1.239 . . . . 74.32 111.35 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -90.73 -61.98 1.55 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.366 1.439 . . . . 55.01 111.476 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -61.48 173.69 0.88 Allowed 'General case' 0 C--N 1.353 0.749 0 CA-C-N 119.265 0.939 . . . . 53.21 112.767 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -120.3 58.37 0.92 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.375 -0.972 . . . . 72.24 108.375 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 t -130.5 170.77 13.79 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 116.552 -1.69 . . . . 62.22 108.079 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.6 m-85 -138.47 160.21 40.11 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 120.131 1.332 . . . . 73.44 110.206 -172.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -80.61 151.1 71.09 Favored Pre-proline 0 C--N 1.357 0.893 0 CA-C-O 116.194 -1.86 . . . . 73.12 107.807 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.36 1.144 0 CA-C-N 123.279 2.207 . . . . 72.35 108.705 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 119.049 -0.501 . . . . 74.51 111.291 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.71 29.57 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-O 119.184 -0.436 . . . . 72.54 110.016 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.0 165.18 12.12 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 108.673 -1.771 . . . . 41.22 108.673 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.63 15.15 10.25 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 124.379 0.693 . . . . 74.43 110.862 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.61 -172.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 72.43 110.834 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.26 7.9 62.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 73.42 112.541 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.04 98.13 7.48 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 118.627 -2.69 . . . . 70.24 106.32 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtm-85 -55.6 148.49 15.81 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-N 119.717 1.144 . . . . 72.15 110.578 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -70.65 -45.12 65.71 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 108.405 -0.961 . . . . 73.53 108.405 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.5 p -135.5 160.05 39.7 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.841 0.713 . . . . 73.41 109.849 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -60.2 -38.09 82.27 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.386 -0.816 . . . . 65.45 111.747 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -82.65 -53.23 6.09 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 119.03 0.832 . . . . 43.3 112.732 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 t -71.81 175.04 6.09 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-N 119.192 0.905 . . . . 73.33 111.548 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -119.68 48.55 1.51 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 108.863 -0.791 . . . . 73.32 108.863 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -120.22 167.49 12.21 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.01 -1.478 . . . . 71.45 107.01 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' SER . 30.2 m-85 -135.42 161.03 36.59 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 119.748 1.158 . . . . 71.35 109.048 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -81.65 151.36 68.08 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 116.368 -1.777 . . . . 61.13 107.968 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--N 1.36 1.175 0 CA-C-N 122.875 2.063 . . . . 64.24 108.59 179.525 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.656 -0.687 . . . . 63.34 111.522 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.78 29.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.393 0.542 . . . . 71.23 110.086 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.23 165.69 12.34 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 108.919 -1.673 . . . . 70.1 108.919 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -123.16 15.22 9.83 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.487 0.757 . . . . 62.12 110.865 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 70.05 110.833 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.18 7.61 62.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.786 -0.721 . . . . 70.14 112.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.05 102.72 11.68 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 118.442 -2.799 . . . . 75.43 105.625 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm-85 -58.39 149.37 25.0 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 120.24 1.382 . . . . 72.4 109.055 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.41 -46.45 66.81 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.47 -1.308 . . . . 73.12 107.47 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.4 p -128.06 169.12 14.41 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.216 0.948 . . . . 75.3 109.734 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.4 ptp -72.27 -30.05 64.47 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.296 -1.335 . . . . 74.23 111.918 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -92.44 -65.45 1.0 Allowed 'General case' 0 C--N 1.356 0.89 0 CA-C-N 120.483 1.492 . . . . 65.44 111.816 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 t -59.64 154.99 16.52 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.722 1.146 . . . . 73.44 112.419 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -96.82 49.85 1.09 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-O 118.693 -0.67 . . . . 73.34 112.147 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -121.66 169.92 10.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-O 116.56 -1.686 . . . . 75.44 109.456 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.2 m-85 -137.55 158.57 44.11 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.945 1.248 . . . . 74.23 110.519 -172.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -80.38 151.07 71.75 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.124 -1.893 . . . . 74.43 107.843 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.36 1.141 0 CA-C-N 123.215 2.184 . . . . 54.34 108.473 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.222 -0.372 0 CA-C-O 118.804 -0.617 . . . . 71.51 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.05 26.27 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 119.003 -0.522 . . . . 71.43 110.334 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.45 165.5 13.1 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 108.71 -1.756 . . . . 65.13 108.71 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.81 15.22 10.1 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 124.409 0.711 . . . . 70.05 110.849 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.4 m -59.69 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 52.11 110.866 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.17 7.09 62.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 32.05 112.517 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.1 95.65 5.92 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.575 -1.544 . . . . 64.51 106.866 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -53.99 147.78 11.86 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 119.828 1.194 . . . . 73.01 109.549 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.34 -47.3 61.67 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 107.585 -1.265 . . . . 73.14 107.585 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -127.32 169.4 13.6 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 124.044 0.84 . . . . 74.32 109.902 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -70.71 -34.98 72.51 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 118.242 -0.885 . . . . 63.15 111.638 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -86.47 -67.79 0.79 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.332 0.969 . . . . 73.34 111.387 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 171.24 0.32 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.107 0.78 . . . . 64.22 113.107 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.42 43.12 2.42 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.563 0.539 . . . . 70.45 110.909 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -114.98 168.63 9.75 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-O 116.984 -1.484 . . . . 73.12 107.559 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.4 m-85 -135.58 160.48 38.37 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.032 1.287 . . . . 62.1 109.487 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -81.11 151.09 69.57 Favored Pre-proline 0 C--N 1.356 0.865 0 CA-C-O 116.244 -1.836 . . . . 72.44 107.742 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.361 1.186 0 CA-C-N 123.02 2.114 . . . . 75.55 108.52 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.513 -0.454 0 CA-C-O 118.836 -0.602 . . . . 73.42 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.82 33.47 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 109.863 -0.421 . . . . 73.31 109.863 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.52 166.09 12.12 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 109.223 -1.551 . . . . 75.43 109.223 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.27 15.08 9.74 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.325 0.662 . . . . 75.44 110.827 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.72 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.861 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.45 62.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 71.15 112.477 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.15 105.23 14.87 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 118.462 -2.787 . . . . 72.42 105.491 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -61.85 149.03 41.42 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.36 1.436 . . . . 75.45 107.779 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -68.66 -44.51 73.95 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 107.392 -1.336 . . . . 72.22 107.392 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.5 p -129.47 171.08 12.91 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.049 0.843 . . . . 60.11 109.606 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 mmt -72.23 -36.71 69.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 117.931 -1.033 . . . . 43.21 110.966 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -86.23 -67.43 0.81 Allowed 'General case' 0 C--N 1.355 0.841 0 CA-C-N 119.864 1.211 . . . . 72.42 111.893 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 t -61.16 153.08 26.84 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.67 1.123 . . . . 74.45 111.041 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -103.01 63.83 0.83 Allowed 'General case' 0 C--N 1.358 0.951 0 N-CA-C 109.304 -0.628 . . . . 75.43 109.304 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -125.71 161.24 27.75 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 116.274 -1.822 . . . . 74.53 107.053 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.3 m-85 -129.55 160.51 33.03 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.959 1.709 . . . . 72.52 109.862 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -81.26 151.62 69.72 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-O 116.294 -1.812 . . . . 72.33 107.953 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.359 1.111 0 CA-C-N 123.05 2.125 . . . . 74.24 108.886 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 118.783 -0.627 . . . . 73.42 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.18 28.69 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-O 119.039 -0.505 . . . . 73.32 110.408 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.47 167.03 12.7 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.978 -1.649 . . . . 64.31 108.978 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -123.72 15.17 9.43 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.421 0.718 . . . . 74.13 110.862 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.48 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.66 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 71.15 110.862 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 7.58 62.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 65.23 112.503 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.42 101.01 10.4 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 118.008 -3.054 . . . . 72.35 105.752 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -57.14 148.59 21.62 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.122 1.328 . . . . 73.44 109.189 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -68.86 -47.67 65.34 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.584 -1.265 . . . . 71.33 107.584 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -125.83 173.32 9.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.273 0.983 . . . . 72.44 109.055 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.0 mmt -72.98 -46.69 50.85 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 119.868 -0.733 . . . . 54.33 109.824 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -73.57 -66.65 0.67 Allowed 'General case' 0 C--N 1.355 0.817 0 CA-C-N 119.042 0.837 . . . . 73.44 111.813 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -60.47 167.9 2.37 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 119.694 1.134 . . . . 64.12 112.487 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.96 71.12 0.79 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.296 -1.372 . . . . 64.45 107.296 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -139.75 169.08 18.39 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.043 -1.932 . . . . 74.11 107.492 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 5' ' ' SER . 16.4 m-85 -137.62 159.36 42.19 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.886 1.675 . . . . 74.43 110.651 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -79.83 149.55 70.86 Favored Pre-proline 0 C--N 1.356 0.883 0 CA-C-O 116.222 -1.847 . . . . 74.42 107.274 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 C--N 1.359 1.127 0 CA-C-N 123.175 2.17 . . . . 74.41 110.092 179.319 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.408 -0.806 . . . . 71.21 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.02 27.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 CA-C-N 118.666 0.666 . . . . 71.23 110.015 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.33 166.13 13.27 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 108.965 -1.654 . . . . 64.31 108.965 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.38 15.16 9.67 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 124.375 0.691 . . . . 54.21 110.871 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -59.64 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.15 110.836 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 6.38 61.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 74.15 112.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.75 107.2 18.09 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 118.797 -2.59 . . . . 72.52 105.772 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.87 151.11 43.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.437 1.471 . . . . 63.42 108.629 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -71.11 -44.21 66.1 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.748 1.158 . . . . 74.14 108.109 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.9 p -135.41 165.16 26.12 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 123.796 0.685 . . . . 72.21 109.477 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.8 mmt -64.91 -43.49 92.67 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 118.746 -0.645 . . . . 73.45 109.932 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.1 m -76.99 -50.88 12.15 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 118.572 -0.727 . . . . 74.31 112.926 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -72.27 174.49 7.19 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 119.29 0.95 . . . . 51.45 111.968 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.55 42.16 2.34 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 118.626 -0.702 . . . . 74.11 110.407 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -118.94 168.76 10.49 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 116.984 -1.484 . . . . 75.33 108.142 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 5' ' ' SER . 29.4 m-85 -137.57 161.55 36.13 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.009 1.277 . . . . 72.51 109.93 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -81.74 150.46 66.11 Favored Pre-proline 0 C--N 1.356 0.853 0 CA-C-O 116.183 -1.865 . . . . 74.41 108.012 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.11 2.146 . . . . 55.33 108.607 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 119.232 -0.414 . . . . 71.42 111.066 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.84 30.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 0 CA-C-O 119.357 -0.354 . . . . 75.5 110.115 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.87 165.49 12.05 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 108.913 -1.675 . . . . 62.43 108.913 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.409 0.711 . . . . 73.23 110.831 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.1 m -59.75 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.86 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 7.07 61.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 52.5 112.48 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.91 102.54 11.97 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 120.119 -1.812 . . . . 73.1 107.231 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.25 150.34 26.04 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.948 1.249 . . . . 74.24 108.965 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.28 -44.89 64.34 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 119.386 0.994 . . . . 75.3 108.334 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -136.13 161.64 35.15 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.801 0.688 . . . . 72.33 109.955 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -58.01 -37.26 73.96 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 118.369 -0.824 . . . . 64.34 111.902 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -87.91 -53.55 4.69 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 118.995 0.816 . . . . 61.24 112.015 -168.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -71.54 171.34 11.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.473 -0.775 . . . . 73.22 110.521 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -118.17 53.15 0.97 Allowed 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.229 -1.026 . . . . 75.43 108.229 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -118.19 166.72 12.25 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.166 -1.79 . . . . 65.3 106.166 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.7 m-85 -134.84 160.8 37.06 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 120.039 1.29 . . . . 73.41 109.27 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -81.0 150.29 68.4 Favored Pre-proline 0 C--N 1.355 0.814 0 CA-C-O 116.426 -1.75 . . . . 75.24 107.731 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.359 1.131 0 CA-C-N 122.719 2.007 . . . . 65.22 108.883 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.682 -0.675 . . . . 73.23 111.444 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.18 30.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 CA-C-N 118.428 0.558 . . . . 65.23 110.048 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.84 165.1 12.07 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.079 -1.609 . . . . 51.21 109.079 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.02 15.18 9.93 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.406 0.709 . . . . 74.31 110.839 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 15.6 m -59.71 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 65.31 110.85 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.22 6.57 61.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 55.42 112.467 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.19 101.58 11.06 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.828 -1.984 . . . . 61.42 106.305 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.23 149.57 23.85 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.181 1.355 . . . . 71.42 109.811 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -70.47 -43.79 69.08 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.012 -1.107 . . . . 51.11 108.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -136.53 162.77 32.18 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 123.877 0.736 . . . . 62.41 109.85 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.4 mmt -61.38 -44.31 97.38 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.916 -0.564 . . . . 74.21 110.064 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 t -74.15 -52.77 11.5 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 112.966 0.728 . . . . 51.22 112.966 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -77.2 177.17 8.09 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.085 0.857 . . . . 73.41 112.62 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -119.14 55.94 0.93 Allowed 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.369 -0.974 . . . . 75.4 108.369 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 t -129.74 170.76 13.44 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 116.762 -1.59 . . . . 72.51 108.025 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 5' ' ' SER . 21.8 m-85 -139.63 161.04 38.48 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.916 1.235 . . . . 73.43 110.273 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -81.55 150.61 67.1 Favored Pre-proline 0 C--N 1.355 0.844 0 CA-C-O 116.522 -1.704 . . . . 73.22 107.788 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.36 1.14 0 CA-C-N 122.879 2.064 . . . . 61.24 110.019 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 118.69 -0.671 . . . . 74.25 111.67 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.42 30.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 CA-C-N 118.365 0.53 . . . . 75.24 109.901 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.76 164.95 12.01 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 109.023 -1.631 . . . . 72.21 109.023 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.01 15.27 9.94 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.375 0.691 . . . . 71.13 110.888 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.452 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.76 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.842 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 6.92 61.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 71.52 112.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.76 107.15 18.02 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 117.646 -3.267 . . . . 74.43 106.929 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.67 152.57 26.21 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.166 1.348 . . . . 75.41 109.038 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -71.81 -43.92 64.79 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.297 -1.001 . . . . 73.34 108.297 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.8 p -137.0 161.42 36.09 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 123.733 0.646 . . . . 72.24 109.925 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -36.49 84.13 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 118.433 -0.794 . . . . 54.24 111.517 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 t -80.48 -50.35 10.18 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 119.215 0.916 . . . . 53.14 112.182 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -72.54 -173.82 1.24 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.753 0.706 . . . . 75.4 111.505 -170.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.63 49.83 2.21 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.594 -0.891 . . . . 75.31 108.594 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -126.2 162.04 26.34 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 116.425 -1.75 . . . . 71.31 106.329 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.9 m-85 -130.57 161.59 31.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 120.831 1.65 . . . . 72.01 109.847 -172.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -79.65 151.0 73.8 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 116.122 -1.894 . . . . 73.34 107.577 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.359 1.092 0 CA-C-N 123.338 2.228 . . . . 62.13 108.641 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 119.216 -0.421 . . . . 73.5 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.36 31.73 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.818 -0.438 . . . . 72.31 109.818 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.27 166.0 12.1 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 108.73 -1.748 . . . . 52.2 108.73 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.68 14.89 9.44 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.371 0.689 . . . . 73.41 110.843 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 3.6 t -59.84 -171.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.841 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.63 6.81 59.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.32 112.509 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.98 110.68 22.93 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 119.68 -2.07 . . . . 73.21 105.608 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.76 151.26 47.02 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.465 1.484 . . . . 74.14 107.125 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -71.18 -52.22 20.42 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 p -126.17 162.63 24.95 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.001 0.813 . . . . 75.13 109.623 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -67.53 -32.93 74.06 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.373 -0.822 . . . . 64.43 111.874 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -83.36 -47.61 11.27 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.144 0.884 . . . . 45.14 112.584 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -75.26 -173.77 2.14 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 118.878 0.763 . . . . 71.11 111.571 -171.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.17 45.38 2.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.328 -0.619 . . . . 72.13 109.328 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -117.47 171.65 7.85 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 106.317 -1.734 . . . . 74.04 106.317 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.2 m-85 -137.96 162.02 35.16 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 120.101 1.319 . . . . 73.32 109.554 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.32 150.82 64.82 Favored Pre-proline 0 C--N 1.355 0.845 0 CA-C-O 116.485 -1.721 . . . . 65.32 108.048 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.36 1.134 0 CA-C-N 122.708 2.003 . . . . 52.14 108.835 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 CA--C 1.514 -0.414 0 CA-C-O 118.868 -0.587 . . . . 74.53 110.825 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.05 30.16 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.783 -0.451 . . . . 73.05 109.783 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.98 165.31 12.15 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 108.849 -1.7 . . . . 61.34 108.849 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.82 14.72 10.05 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 124.448 0.734 . . . . 73.1 110.894 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.495 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.8 -171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 53.14 110.831 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.73 59.1 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 70.45 112.475 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.94 114.98 29.62 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 117.41 -3.406 . . . . 64.23 105.243 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -66.84 150.84 48.59 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.984 1.72 . . . . 71.5 106.749 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.8 -50.91 38.4 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.4 -1.333 . . . . 62.43 107.4 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 p -128.59 162.13 28.01 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 123.946 0.779 . . . . 72.11 110.075 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -61.63 -39.15 90.26 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.265 -0.874 . . . . 72.32 111.897 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -83.45 -51.71 7.14 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 119.201 0.91 . . . . 63.34 111.895 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 t -70.0 175.45 4.43 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.944 0.793 . . . . 74.34 110.713 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -127.14 49.67 2.06 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.11 -1.07 . . . . 71.34 108.11 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -118.16 173.55 6.73 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.468 -1.678 . . . . 70.22 106.468 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.2 m-85 -138.59 161.24 37.59 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.746 1.612 . . . . 74.44 109.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -82.1 151.33 66.5 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.217 -1.849 . . . . 74.44 108.069 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.104 2.144 . . . . 51.22 108.646 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.834 -0.603 . . . . 72.44 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.63 31.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.848 -0.427 . . . . 62.55 109.848 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.44 166.94 12.32 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 108.935 -1.666 . . . . 75.45 108.935 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.0 14.8 9.2 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 124.432 0.724 . . . . 73.44 110.839 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.2 t -59.83 -172.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.873 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.33 58.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.761 . . . . 62.52 112.465 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.69 115.85 31.24 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 118.535 -2.744 . . . . 74.23 105.599 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.21 150.22 48.57 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.862 1.664 . . . . 74.31 106.74 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.26 -45.99 65.29 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 119.905 1.23 . . . . 71.35 108.312 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -130.37 167.15 19.01 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.008 0.817 . . . . 74.55 109.145 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.4 mmt -69.13 -38.56 78.92 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 118.374 -0.822 . . . . 52.22 110.42 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 t -82.86 -52.76 6.43 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.132 0.878 . . . . 44.13 112.524 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -70.67 177.19 3.65 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 119.51 1.05 . . . . 63.02 112.028 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 pm0 -121.2 49.01 1.55 Allowed 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.246 -0.65 . . . . 75.32 109.246 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -118.67 171.03 8.47 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 116.899 -1.524 . . . . 54.42 107.884 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 5' ' ' SER . 19.1 m-85 -139.28 160.18 40.43 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.038 1.29 . . . . 71.42 110.238 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -81.96 151.06 66.59 Favored Pre-proline 0 C--N 1.356 0.884 0 CA-C-O 116.358 -1.782 . . . . 72.34 108.151 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 C--N 1.36 1.174 0 CA-C-N 122.793 2.033 . . . . 74.11 110.133 179.241 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 118.875 -0.583 . . . . 72.2 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.75 33.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.696 -0.483 . . . . 62.53 109.696 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.65 12.18 Favored Glycine 0 C--N 1.354 1.537 0 N-CA-C 109.047 -1.621 . . . . 72.04 109.047 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.69 15.14 9.45 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 124.397 0.704 . . . . 65.13 110.823 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -59.67 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 54.42 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.27 6.2 61.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.3 112.49 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.49 102.72 12.17 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 119.203 -2.351 . . . . 54.21 106.09 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -57.48 150.42 18.8 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.099 1.318 . . . . 72.0 109.438 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -71.44 -51.32 24.5 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 107.36 -1.348 . . . . 73.21 107.36 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 p -125.72 162.77 24.3 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.045 0.841 . . . . 74.31 109.829 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -64.68 -35.42 80.97 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.375 -0.821 . . . . 73.11 111.788 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -85.74 -51.2 6.59 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 119.074 0.852 . . . . 73.14 112.298 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -72.89 176.82 5.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.098 0.863 . . . . 71.44 111.811 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 52.44 1.25 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.728 -0.842 . . . . 71.15 108.728 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 t -122.91 170.51 10.05 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 116.799 -1.572 . . . . 75.13 107.499 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 5' ' ' SER . 23.9 m-85 -138.62 161.07 38.05 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 119.924 1.238 . . . . 71.04 109.905 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -82.49 151.52 65.52 Favored Pre-proline 0 C--N 1.355 0.833 0 CA-C-O 116.391 -1.766 . . . . 72.04 108.268 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 C--N 1.361 1.206 0 CA-C-N 122.762 2.022 . . . . 75.34 108.812 -179.729 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.522 -0.751 . . . . 34.31 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.7 28.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 118.4 0.545 . . . . 53.14 110.093 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.78 166.15 12.49 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.124 -1.59 . . . . 71.02 109.124 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.51 15.19 9.58 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 124.458 0.74 . . . . 64.13 110.917 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -59.64 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.881 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.52 62.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 51.45 112.446 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.2 mt -107.22 99.29 8.84 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 119.105 -2.409 . . . . 71.05 106.981 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -54.71 150.32 9.78 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 119.627 1.103 . . . . 75.4 109.729 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -72.21 -50.51 26.96 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 107.5 -1.296 . . . . 75.25 107.5 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.4 p -128.75 160.75 31.55 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 123.91 0.756 . . . . 65.23 110.137 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -60.41 -38.55 84.37 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 118.235 -0.888 . . . . 73.3 112.197 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 t -82.53 -52.92 6.39 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.311 0.959 . . . . 63.43 111.494 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -70.14 169.24 13.96 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 118.733 0.697 . . . . 70.04 111.414 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -119.66 65.74 0.8 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.518 -1.66 . . . . 33.35 106.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 t -139.31 161.08 38.32 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 115.646 -2.121 . . . . 74.24 106.415 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 5' ' ' SER . 20.8 m-85 -132.61 161.29 34.25 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.804 2.093 . . . . 71.13 110.612 -169.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.45 150.64 70.81 Favored Pre-proline 0 C--N 1.357 0.914 0 CA-C-O 116.322 -1.799 . . . . 73.32 107.64 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 C--N 1.359 1.123 0 CA-C-N 123.048 2.124 . . . . 74.0 108.584 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.533 -0.746 . . . . 35.1 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.89 30.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 118.521 0.6 . . . . 52.55 109.898 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.56 165.74 12.09 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.084 -1.606 . . . . 51.14 109.084 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.61 15.08 9.51 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 124.435 0.727 . . . . 75.12 110.875 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.44 110.866 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 8.12 62.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 63.12 112.465 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.99 99.29 8.75 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 118.843 -2.563 . . . . 73.55 106.072 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -55.04 148.11 14.42 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 119.8 1.182 . . . . 72.11 109.279 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.22 -46.75 66.62 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 107.498 -1.297 . . . . 74.14 107.498 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.9 p -127.12 171.54 11.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.208 0.943 . . . . 61.35 109.932 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -33.73 65.81 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 117.499 -1.239 . . . . 74.32 111.35 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -90.73 -61.98 1.55 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.366 1.439 . . . . 55.01 111.476 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -61.48 173.69 0.88 Allowed 'General case' 0 C--N 1.353 0.749 0 CA-C-N 119.265 0.939 . . . . 53.21 112.767 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -120.3 58.37 0.92 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.375 -0.972 . . . . 72.24 108.375 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 t -130.5 170.77 13.79 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 116.552 -1.69 . . . . 62.22 108.079 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.6 m-85 -138.47 160.21 40.11 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 120.131 1.332 . . . . 73.44 110.206 -172.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -80.61 151.1 71.09 Favored Pre-proline 0 C--N 1.357 0.893 0 CA-C-O 116.194 -1.86 . . . . 73.12 107.807 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.36 1.144 0 CA-C-N 123.279 2.207 . . . . 72.35 108.705 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 119.049 -0.501 . . . . 74.51 111.291 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.71 29.57 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-O 119.184 -0.436 . . . . 72.54 110.016 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.0 165.18 12.12 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 108.673 -1.771 . . . . 41.22 108.673 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.63 15.15 10.25 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 124.379 0.693 . . . . 74.43 110.862 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.61 -172.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 72.43 110.834 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.26 7.9 62.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 73.42 112.541 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.04 98.13 7.48 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 118.627 -2.69 . . . . 70.24 106.32 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtm-85 -55.6 148.49 15.81 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-N 119.717 1.144 . . . . 72.15 110.578 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -70.65 -45.12 65.71 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 108.405 -0.961 . . . . 73.53 108.405 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.5 p -135.5 160.05 39.7 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.841 0.713 . . . . 73.41 109.849 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -60.2 -38.09 82.27 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.386 -0.816 . . . . 65.45 111.747 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -82.65 -53.23 6.09 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 119.03 0.832 . . . . 43.3 112.732 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 t -71.81 175.04 6.09 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-N 119.192 0.905 . . . . 73.33 111.548 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -119.68 48.55 1.51 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 108.863 -0.791 . . . . 73.32 108.863 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -120.22 167.49 12.21 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.01 -1.478 . . . . 71.45 107.01 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' SER . 30.2 m-85 -135.42 161.03 36.59 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 119.748 1.158 . . . . 71.35 109.048 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -81.65 151.36 68.08 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 116.368 -1.777 . . . . 61.13 107.968 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--N 1.36 1.175 0 CA-C-N 122.875 2.063 . . . . 64.24 108.59 179.525 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.656 -0.687 . . . . 63.34 111.522 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.78 29.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.393 0.542 . . . . 71.23 110.086 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.23 165.69 12.34 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 108.919 -1.673 . . . . 70.1 108.919 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -123.16 15.22 9.83 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.487 0.757 . . . . 62.12 110.865 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 70.05 110.833 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.18 7.61 62.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.786 -0.721 . . . . 70.14 112.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.05 102.72 11.68 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 118.442 -2.799 . . . . 75.43 105.625 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm-85 -58.39 149.37 25.0 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 120.24 1.382 . . . . 72.4 109.055 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.41 -46.45 66.81 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.47 -1.308 . . . . 73.12 107.47 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.4 p -128.06 169.12 14.41 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.216 0.948 . . . . 75.3 109.734 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.4 ptp -72.27 -30.05 64.47 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.296 -1.335 . . . . 74.23 111.918 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -92.44 -65.45 1.0 Allowed 'General case' 0 C--N 1.356 0.89 0 CA-C-N 120.483 1.492 . . . . 65.44 111.816 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 t -59.64 154.99 16.52 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.722 1.146 . . . . 73.44 112.419 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -96.82 49.85 1.09 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-O 118.693 -0.67 . . . . 73.34 112.147 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -121.66 169.92 10.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-O 116.56 -1.686 . . . . 75.44 109.456 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.2 m-85 -137.55 158.57 44.11 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.945 1.248 . . . . 74.23 110.519 -172.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -80.38 151.07 71.75 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.124 -1.893 . . . . 74.43 107.843 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.36 1.141 0 CA-C-N 123.215 2.184 . . . . 54.34 108.473 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.222 -0.372 0 CA-C-O 118.804 -0.617 . . . . 71.51 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.05 26.27 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 119.003 -0.522 . . . . 71.43 110.334 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.45 165.5 13.1 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 108.71 -1.756 . . . . 65.13 108.71 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.81 15.22 10.1 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 124.409 0.711 . . . . 70.05 110.849 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.4 m -59.69 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 52.11 110.866 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.17 7.09 62.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 32.05 112.517 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.1 95.65 5.92 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.575 -1.544 . . . . 64.51 106.866 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -53.99 147.78 11.86 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 119.828 1.194 . . . . 73.01 109.549 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.34 -47.3 61.67 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 107.585 -1.265 . . . . 73.14 107.585 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -127.32 169.4 13.6 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 124.044 0.84 . . . . 74.32 109.902 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -70.71 -34.98 72.51 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 118.242 -0.885 . . . . 63.15 111.638 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -86.47 -67.79 0.79 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.332 0.969 . . . . 73.34 111.387 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 171.24 0.32 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.107 0.78 . . . . 64.22 113.107 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.42 43.12 2.42 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.563 0.539 . . . . 70.45 110.909 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -114.98 168.63 9.75 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-O 116.984 -1.484 . . . . 73.12 107.559 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.4 m-85 -135.58 160.48 38.37 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.032 1.287 . . . . 62.1 109.487 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -81.11 151.09 69.57 Favored Pre-proline 0 C--N 1.356 0.865 0 CA-C-O 116.244 -1.836 . . . . 72.44 107.742 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.361 1.186 0 CA-C-N 123.02 2.114 . . . . 75.55 108.52 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.513 -0.454 0 CA-C-O 118.836 -0.602 . . . . 73.42 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.82 33.47 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 109.863 -0.421 . . . . 73.31 109.863 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.52 166.09 12.12 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 109.223 -1.551 . . . . 75.43 109.223 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.27 15.08 9.74 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.325 0.662 . . . . 75.44 110.827 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.72 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.861 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.45 62.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 71.15 112.477 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.15 105.23 14.87 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 118.462 -2.787 . . . . 72.42 105.491 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -61.85 149.03 41.42 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.36 1.436 . . . . 75.45 107.779 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -68.66 -44.51 73.95 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 107.392 -1.336 . . . . 72.22 107.392 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.5 p -129.47 171.08 12.91 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.049 0.843 . . . . 60.11 109.606 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 mmt -72.23 -36.71 69.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 117.931 -1.033 . . . . 43.21 110.966 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -86.23 -67.43 0.81 Allowed 'General case' 0 C--N 1.355 0.841 0 CA-C-N 119.864 1.211 . . . . 72.42 111.893 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 t -61.16 153.08 26.84 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.67 1.123 . . . . 74.45 111.041 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -103.01 63.83 0.83 Allowed 'General case' 0 C--N 1.358 0.951 0 N-CA-C 109.304 -0.628 . . . . 75.43 109.304 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -125.71 161.24 27.75 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 116.274 -1.822 . . . . 74.53 107.053 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.3 m-85 -129.55 160.51 33.03 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.959 1.709 . . . . 72.52 109.862 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -81.26 151.62 69.72 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-O 116.294 -1.812 . . . . 72.33 107.953 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.359 1.111 0 CA-C-N 123.05 2.125 . . . . 74.24 108.886 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 118.783 -0.627 . . . . 73.42 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.18 28.69 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-O 119.039 -0.505 . . . . 73.32 110.408 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.47 167.03 12.7 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.978 -1.649 . . . . 64.31 108.978 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -123.72 15.17 9.43 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.421 0.718 . . . . 74.13 110.862 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.48 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.66 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 71.15 110.862 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 7.58 62.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 65.23 112.503 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.42 101.01 10.4 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 118.008 -3.054 . . . . 72.35 105.752 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -57.14 148.59 21.62 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.122 1.328 . . . . 73.44 109.189 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -68.86 -47.67 65.34 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.584 -1.265 . . . . 71.33 107.584 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -125.83 173.32 9.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.273 0.983 . . . . 72.44 109.055 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.0 mmt -72.98 -46.69 50.85 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 119.868 -0.733 . . . . 54.33 109.824 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -73.57 -66.65 0.67 Allowed 'General case' 0 C--N 1.355 0.817 0 CA-C-N 119.042 0.837 . . . . 73.44 111.813 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -60.47 167.9 2.37 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 119.694 1.134 . . . . 64.12 112.487 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.96 71.12 0.79 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.296 -1.372 . . . . 64.45 107.296 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -139.75 169.08 18.39 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.043 -1.932 . . . . 74.11 107.492 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 5' ' ' SER . 16.4 m-85 -137.62 159.36 42.19 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.886 1.675 . . . . 74.43 110.651 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -79.83 149.55 70.86 Favored Pre-proline 0 C--N 1.356 0.883 0 CA-C-O 116.222 -1.847 . . . . 74.42 107.274 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 C--N 1.359 1.127 0 CA-C-N 123.175 2.17 . . . . 74.41 110.092 179.319 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.408 -0.806 . . . . 71.21 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.02 27.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 CA-C-N 118.666 0.666 . . . . 71.23 110.015 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.33 166.13 13.27 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 108.965 -1.654 . . . . 64.31 108.965 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.38 15.16 9.67 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 124.375 0.691 . . . . 54.21 110.871 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -59.64 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.15 110.836 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 6.38 61.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 74.15 112.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.75 107.2 18.09 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 118.797 -2.59 . . . . 72.52 105.772 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.87 151.11 43.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.437 1.471 . . . . 63.42 108.629 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -71.11 -44.21 66.1 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.748 1.158 . . . . 74.14 108.109 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.9 p -135.41 165.16 26.12 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 123.796 0.685 . . . . 72.21 109.477 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.8 mmt -64.91 -43.49 92.67 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 118.746 -0.645 . . . . 73.45 109.932 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.1 m -76.99 -50.88 12.15 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 118.572 -0.727 . . . . 74.31 112.926 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -72.27 174.49 7.19 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 119.29 0.95 . . . . 51.45 111.968 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.55 42.16 2.34 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 118.626 -0.702 . . . . 74.11 110.407 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -118.94 168.76 10.49 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 116.984 -1.484 . . . . 75.33 108.142 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 5' ' ' SER . 29.4 m-85 -137.57 161.55 36.13 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.009 1.277 . . . . 72.51 109.93 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -81.74 150.46 66.11 Favored Pre-proline 0 C--N 1.356 0.853 0 CA-C-O 116.183 -1.865 . . . . 74.41 108.012 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.11 2.146 . . . . 55.33 108.607 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 119.232 -0.414 . . . . 71.42 111.066 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.84 30.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 0 CA-C-O 119.357 -0.354 . . . . 75.5 110.115 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.87 165.49 12.05 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 108.913 -1.675 . . . . 62.43 108.913 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.409 0.711 . . . . 73.23 110.831 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.1 m -59.75 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.86 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 7.07 61.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 52.5 112.48 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.91 102.54 11.97 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 120.119 -1.812 . . . . 73.1 107.231 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.25 150.34 26.04 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.948 1.249 . . . . 74.24 108.965 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.28 -44.89 64.34 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 119.386 0.994 . . . . 75.3 108.334 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -136.13 161.64 35.15 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.801 0.688 . . . . 72.33 109.955 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -58.01 -37.26 73.96 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 118.369 -0.824 . . . . 64.34 111.902 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -87.91 -53.55 4.69 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 118.995 0.816 . . . . 61.24 112.015 -168.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -71.54 171.34 11.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.473 -0.775 . . . . 73.22 110.521 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -118.17 53.15 0.97 Allowed 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.229 -1.026 . . . . 75.43 108.229 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -118.19 166.72 12.25 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.166 -1.79 . . . . 65.3 106.166 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.7 m-85 -134.84 160.8 37.06 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 120.039 1.29 . . . . 73.41 109.27 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -81.0 150.29 68.4 Favored Pre-proline 0 C--N 1.355 0.814 0 CA-C-O 116.426 -1.75 . . . . 75.24 107.731 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.359 1.131 0 CA-C-N 122.719 2.007 . . . . 65.22 108.883 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.682 -0.675 . . . . 73.23 111.444 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.18 30.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 CA-C-N 118.428 0.558 . . . . 65.23 110.048 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.84 165.1 12.07 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.079 -1.609 . . . . 51.21 109.079 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.02 15.18 9.93 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.406 0.709 . . . . 74.31 110.839 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 15.6 m -59.71 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 65.31 110.85 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.22 6.57 61.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 55.42 112.467 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.19 101.58 11.06 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.828 -1.984 . . . . 61.42 106.305 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.23 149.57 23.85 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.181 1.355 . . . . 71.42 109.811 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -70.47 -43.79 69.08 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.012 -1.107 . . . . 51.11 108.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -136.53 162.77 32.18 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 123.877 0.736 . . . . 62.41 109.85 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.4 mmt -61.38 -44.31 97.38 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.916 -0.564 . . . . 74.21 110.064 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 t -74.15 -52.77 11.5 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 112.966 0.728 . . . . 51.22 112.966 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -77.2 177.17 8.09 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.085 0.857 . . . . 73.41 112.62 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -119.14 55.94 0.93 Allowed 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.369 -0.974 . . . . 75.4 108.369 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 t -129.74 170.76 13.44 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 116.762 -1.59 . . . . 72.51 108.025 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 5' ' ' SER . 21.8 m-85 -139.63 161.04 38.48 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.916 1.235 . . . . 73.43 110.273 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -81.55 150.61 67.1 Favored Pre-proline 0 C--N 1.355 0.844 0 CA-C-O 116.522 -1.704 . . . . 73.22 107.788 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.36 1.14 0 CA-C-N 122.879 2.064 . . . . 61.24 110.019 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 118.69 -0.671 . . . . 74.25 111.67 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.42 30.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 CA-C-N 118.365 0.53 . . . . 75.24 109.901 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.76 164.95 12.01 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 109.023 -1.631 . . . . 72.21 109.023 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.01 15.27 9.94 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.375 0.691 . . . . 71.13 110.888 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.452 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.76 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.842 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 6.92 61.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 71.52 112.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.76 107.15 18.02 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 117.646 -3.267 . . . . 74.43 106.929 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.67 152.57 26.21 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.166 1.348 . . . . 75.41 109.038 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -71.81 -43.92 64.79 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.297 -1.001 . . . . 73.34 108.297 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.8 p -137.0 161.42 36.09 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 123.733 0.646 . . . . 72.24 109.925 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -36.49 84.13 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 118.433 -0.794 . . . . 54.24 111.517 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 t -80.48 -50.35 10.18 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 119.215 0.916 . . . . 53.14 112.182 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -72.54 -173.82 1.24 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.753 0.706 . . . . 75.4 111.505 -170.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.63 49.83 2.21 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.594 -0.891 . . . . 75.31 108.594 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -126.2 162.04 26.34 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 116.425 -1.75 . . . . 71.31 106.329 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.9 m-85 -130.57 161.59 31.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 120.831 1.65 . . . . 72.01 109.847 -172.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -79.65 151.0 73.8 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 116.122 -1.894 . . . . 73.34 107.577 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.359 1.092 0 CA-C-N 123.338 2.228 . . . . 62.13 108.641 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 119.216 -0.421 . . . . 73.5 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.36 31.73 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.818 -0.438 . . . . 72.31 109.818 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.27 166.0 12.1 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 108.73 -1.748 . . . . 52.2 108.73 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.68 14.89 9.44 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.371 0.689 . . . . 73.41 110.843 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 3.6 t -59.84 -171.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.841 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.63 6.81 59.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.32 112.509 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.98 110.68 22.93 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 119.68 -2.07 . . . . 73.21 105.608 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.76 151.26 47.02 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.465 1.484 . . . . 74.14 107.125 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -71.18 -52.22 20.42 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 p -126.17 162.63 24.95 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.001 0.813 . . . . 75.13 109.623 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -67.53 -32.93 74.06 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.373 -0.822 . . . . 64.43 111.874 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -83.36 -47.61 11.27 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.144 0.884 . . . . 45.14 112.584 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -75.26 -173.77 2.14 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 118.878 0.763 . . . . 71.11 111.571 -171.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.17 45.38 2.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.328 -0.619 . . . . 72.13 109.328 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -117.47 171.65 7.85 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 106.317 -1.734 . . . . 74.04 106.317 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.2 m-85 -137.96 162.02 35.16 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 120.101 1.319 . . . . 73.32 109.554 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.32 150.82 64.82 Favored Pre-proline 0 C--N 1.355 0.845 0 CA-C-O 116.485 -1.721 . . . . 65.32 108.048 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.36 1.134 0 CA-C-N 122.708 2.003 . . . . 52.14 108.835 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 CA--C 1.514 -0.414 0 CA-C-O 118.868 -0.587 . . . . 74.53 110.825 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.05 30.16 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.783 -0.451 . . . . 73.05 109.783 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.98 165.31 12.15 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 108.849 -1.7 . . . . 61.34 108.849 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.82 14.72 10.05 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 124.448 0.734 . . . . 73.1 110.894 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.495 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.8 -171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 53.14 110.831 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.73 59.1 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 70.45 112.475 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.94 114.98 29.62 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 117.41 -3.406 . . . . 64.23 105.243 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -66.84 150.84 48.59 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.984 1.72 . . . . 71.5 106.749 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.8 -50.91 38.4 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.4 -1.333 . . . . 62.43 107.4 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 p -128.59 162.13 28.01 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 123.946 0.779 . . . . 72.11 110.075 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -61.63 -39.15 90.26 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.265 -0.874 . . . . 72.32 111.897 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -83.45 -51.71 7.14 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 119.201 0.91 . . . . 63.34 111.895 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 t -70.0 175.45 4.43 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.944 0.793 . . . . 74.34 110.713 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -127.14 49.67 2.06 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.11 -1.07 . . . . 71.34 108.11 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -118.16 173.55 6.73 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.468 -1.678 . . . . 70.22 106.468 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.2 m-85 -138.59 161.24 37.59 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.746 1.612 . . . . 74.44 109.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -82.1 151.33 66.5 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.217 -1.849 . . . . 74.44 108.069 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.104 2.144 . . . . 51.22 108.646 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.834 -0.603 . . . . 72.44 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.63 31.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.848 -0.427 . . . . 62.55 109.848 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.44 166.94 12.32 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 108.935 -1.666 . . . . 75.45 108.935 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.0 14.8 9.2 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 124.432 0.724 . . . . 73.44 110.839 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.2 t -59.83 -172.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.873 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.33 58.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.761 . . . . 62.52 112.465 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.69 115.85 31.24 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 118.535 -2.744 . . . . 74.23 105.599 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.21 150.22 48.57 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.862 1.664 . . . . 74.31 106.74 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.26 -45.99 65.29 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 119.905 1.23 . . . . 71.35 108.312 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -130.37 167.15 19.01 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.008 0.817 . . . . 74.55 109.145 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.4 mmt -69.13 -38.56 78.92 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 118.374 -0.822 . . . . 52.22 110.42 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 t -82.86 -52.76 6.43 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.132 0.878 . . . . 44.13 112.524 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -70.67 177.19 3.65 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 119.51 1.05 . . . . 63.02 112.028 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 pm0 -121.2 49.01 1.55 Allowed 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.246 -0.65 . . . . 75.32 109.246 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -118.67 171.03 8.47 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 116.899 -1.524 . . . . 54.42 107.884 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 5' ' ' SER . 19.1 m-85 -139.28 160.18 40.43 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.038 1.29 . . . . 71.42 110.238 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -81.96 151.06 66.59 Favored Pre-proline 0 C--N 1.356 0.884 0 CA-C-O 116.358 -1.782 . . . . 72.34 108.151 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 C--N 1.36 1.174 0 CA-C-N 122.793 2.033 . . . . 74.11 110.133 179.241 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 118.875 -0.583 . . . . 72.2 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.75 33.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.696 -0.483 . . . . 62.53 109.696 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.65 12.18 Favored Glycine 0 C--N 1.354 1.537 0 N-CA-C 109.047 -1.621 . . . . 72.04 109.047 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.69 15.14 9.45 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 124.397 0.704 . . . . 65.13 110.823 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -59.67 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 54.42 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.27 6.2 61.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.3 112.49 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.49 102.72 12.17 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 119.203 -2.351 . . . . 54.21 106.09 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -57.48 150.42 18.8 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.099 1.318 . . . . 72.0 109.438 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -71.44 -51.32 24.5 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 107.36 -1.348 . . . . 73.21 107.36 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 p -125.72 162.77 24.3 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.045 0.841 . . . . 74.31 109.829 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -64.68 -35.42 80.97 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.375 -0.821 . . . . 73.11 111.788 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -85.74 -51.2 6.59 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 119.074 0.852 . . . . 73.14 112.298 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -72.89 176.82 5.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.098 0.863 . . . . 71.44 111.811 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 52.44 1.25 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.728 -0.842 . . . . 71.15 108.728 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 t -122.91 170.51 10.05 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 116.799 -1.572 . . . . 75.13 107.499 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 5' ' ' SER . 23.9 m-85 -138.62 161.07 38.05 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 119.924 1.238 . . . . 71.04 109.905 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -82.49 151.52 65.52 Favored Pre-proline 0 C--N 1.355 0.833 0 CA-C-O 116.391 -1.766 . . . . 72.04 108.268 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 C--N 1.361 1.206 0 CA-C-N 122.762 2.022 . . . . 75.34 108.812 -179.729 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.522 -0.751 . . . . 34.31 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.7 28.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 118.4 0.545 . . . . 53.14 110.093 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.78 166.15 12.49 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.124 -1.59 . . . . 71.02 109.124 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.51 15.19 9.58 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 124.458 0.74 . . . . 64.13 110.917 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -59.64 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.881 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.52 62.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 51.45 112.446 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.2 mt -107.22 99.29 8.84 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 119.105 -2.409 . . . . 71.05 106.981 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -54.71 150.32 9.78 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 119.627 1.103 . . . . 75.4 109.729 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -72.21 -50.51 26.96 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 107.5 -1.296 . . . . 75.25 107.5 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.4 p -128.75 160.75 31.55 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 123.91 0.756 . . . . 65.23 110.137 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -60.41 -38.55 84.37 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 118.235 -0.888 . . . . 73.3 112.197 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 t -82.53 -52.92 6.39 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.311 0.959 . . . . 63.43 111.494 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -70.14 169.24 13.96 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 118.733 0.697 . . . . 70.04 111.414 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -119.66 65.74 0.8 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.518 -1.66 . . . . 33.35 106.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 t -139.31 161.08 38.32 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 115.646 -2.121 . . . . 74.24 106.415 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 5' ' ' SER . 20.8 m-85 -132.61 161.29 34.25 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.804 2.093 . . . . 71.13 110.612 -169.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.45 150.64 70.81 Favored Pre-proline 0 C--N 1.357 0.914 0 CA-C-O 116.322 -1.799 . . . . 73.32 107.64 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 C--N 1.359 1.123 0 CA-C-N 123.048 2.124 . . . . 74.0 108.584 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.533 -0.746 . . . . 35.1 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.89 30.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 118.521 0.6 . . . . 52.55 109.898 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.56 165.74 12.09 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.084 -1.606 . . . . 51.14 109.084 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.61 15.08 9.51 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 124.435 0.727 . . . . 75.12 110.875 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.44 110.866 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 8.12 62.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 63.12 112.465 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.99 99.29 8.75 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 118.843 -2.563 . . . . 73.55 106.072 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -55.04 148.11 14.42 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 119.8 1.182 . . . . 72.11 109.279 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.22 -46.75 66.62 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 107.498 -1.297 . . . . 74.14 107.498 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.9 p -127.12 171.54 11.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.208 0.943 . . . . 61.35 109.932 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -33.73 65.81 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 117.499 -1.239 . . . . 74.32 111.35 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -90.73 -61.98 1.55 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.366 1.439 . . . . 55.01 111.476 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -61.48 173.69 0.88 Allowed 'General case' 0 C--N 1.353 0.749 0 CA-C-N 119.265 0.939 . . . . 53.21 112.767 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -120.3 58.37 0.92 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.375 -0.972 . . . . 72.24 108.375 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 t -130.5 170.77 13.79 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 116.552 -1.69 . . . . 62.22 108.079 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.6 m-85 -138.47 160.21 40.11 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 120.131 1.332 . . . . 73.44 110.206 -172.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -80.61 151.1 71.09 Favored Pre-proline 0 C--N 1.357 0.893 0 CA-C-O 116.194 -1.86 . . . . 73.12 107.807 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.36 1.144 0 CA-C-N 123.279 2.207 . . . . 72.35 108.705 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 119.049 -0.501 . . . . 74.51 111.291 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.71 29.57 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-O 119.184 -0.436 . . . . 72.54 110.016 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.0 165.18 12.12 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 108.673 -1.771 . . . . 41.22 108.673 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.63 15.15 10.25 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 124.379 0.693 . . . . 74.43 110.862 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.61 -172.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 72.43 110.834 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.26 7.9 62.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 73.42 112.541 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.04 98.13 7.48 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 118.627 -2.69 . . . . 70.24 106.32 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtm-85 -55.6 148.49 15.81 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-N 119.717 1.144 . . . . 72.15 110.578 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -70.65 -45.12 65.71 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 108.405 -0.961 . . . . 73.53 108.405 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.5 p -135.5 160.05 39.7 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.841 0.713 . . . . 73.41 109.849 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -60.2 -38.09 82.27 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.386 -0.816 . . . . 65.45 111.747 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -82.65 -53.23 6.09 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 119.03 0.832 . . . . 43.3 112.732 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 t -71.81 175.04 6.09 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-N 119.192 0.905 . . . . 73.33 111.548 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -119.68 48.55 1.51 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 108.863 -0.791 . . . . 73.32 108.863 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -120.22 167.49 12.21 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.01 -1.478 . . . . 71.45 107.01 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' SER . 30.2 m-85 -135.42 161.03 36.59 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 119.748 1.158 . . . . 71.35 109.048 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -81.65 151.36 68.08 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 116.368 -1.777 . . . . 61.13 107.968 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--N 1.36 1.175 0 CA-C-N 122.875 2.063 . . . . 64.24 108.59 179.525 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.656 -0.687 . . . . 63.34 111.522 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.78 29.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.393 0.542 . . . . 71.23 110.086 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.23 165.69 12.34 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 108.919 -1.673 . . . . 70.1 108.919 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -123.16 15.22 9.83 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.487 0.757 . . . . 62.12 110.865 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 70.05 110.833 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.18 7.61 62.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.786 -0.721 . . . . 70.14 112.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.05 102.72 11.68 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 118.442 -2.799 . . . . 75.43 105.625 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm-85 -58.39 149.37 25.0 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 120.24 1.382 . . . . 72.4 109.055 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.41 -46.45 66.81 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.47 -1.308 . . . . 73.12 107.47 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.4 p -128.06 169.12 14.41 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.216 0.948 . . . . 75.3 109.734 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.4 ptp -72.27 -30.05 64.47 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.296 -1.335 . . . . 74.23 111.918 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -92.44 -65.45 1.0 Allowed 'General case' 0 C--N 1.356 0.89 0 CA-C-N 120.483 1.492 . . . . 65.44 111.816 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 t -59.64 154.99 16.52 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.722 1.146 . . . . 73.44 112.419 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -96.82 49.85 1.09 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-O 118.693 -0.67 . . . . 73.34 112.147 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -121.66 169.92 10.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-O 116.56 -1.686 . . . . 75.44 109.456 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.2 m-85 -137.55 158.57 44.11 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.945 1.248 . . . . 74.23 110.519 -172.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -80.38 151.07 71.75 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.124 -1.893 . . . . 74.43 107.843 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.36 1.141 0 CA-C-N 123.215 2.184 . . . . 54.34 108.473 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.222 -0.372 0 CA-C-O 118.804 -0.617 . . . . 71.51 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.05 26.27 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 119.003 -0.522 . . . . 71.43 110.334 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.45 165.5 13.1 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 108.71 -1.756 . . . . 65.13 108.71 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.81 15.22 10.1 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 124.409 0.711 . . . . 70.05 110.849 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.4 m -59.69 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 52.11 110.866 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.17 7.09 62.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 32.05 112.517 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.1 95.65 5.92 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.575 -1.544 . . . . 64.51 106.866 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -53.99 147.78 11.86 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 119.828 1.194 . . . . 73.01 109.549 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.34 -47.3 61.67 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 107.585 -1.265 . . . . 73.14 107.585 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -127.32 169.4 13.6 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 124.044 0.84 . . . . 74.32 109.902 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -70.71 -34.98 72.51 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 118.242 -0.885 . . . . 63.15 111.638 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -86.47 -67.79 0.79 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.332 0.969 . . . . 73.34 111.387 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 171.24 0.32 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.107 0.78 . . . . 64.22 113.107 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.42 43.12 2.42 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.563 0.539 . . . . 70.45 110.909 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -114.98 168.63 9.75 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-O 116.984 -1.484 . . . . 73.12 107.559 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.4 m-85 -135.58 160.48 38.37 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.032 1.287 . . . . 62.1 109.487 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -81.11 151.09 69.57 Favored Pre-proline 0 C--N 1.356 0.865 0 CA-C-O 116.244 -1.836 . . . . 72.44 107.742 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.361 1.186 0 CA-C-N 123.02 2.114 . . . . 75.55 108.52 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.513 -0.454 0 CA-C-O 118.836 -0.602 . . . . 73.42 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.82 33.47 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 109.863 -0.421 . . . . 73.31 109.863 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.52 166.09 12.12 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 109.223 -1.551 . . . . 75.43 109.223 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.27 15.08 9.74 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.325 0.662 . . . . 75.44 110.827 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.72 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.861 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.45 62.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 71.15 112.477 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.15 105.23 14.87 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 118.462 -2.787 . . . . 72.42 105.491 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -61.85 149.03 41.42 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.36 1.436 . . . . 75.45 107.779 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -68.66 -44.51 73.95 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 107.392 -1.336 . . . . 72.22 107.392 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.5 p -129.47 171.08 12.91 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.049 0.843 . . . . 60.11 109.606 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 mmt -72.23 -36.71 69.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 117.931 -1.033 . . . . 43.21 110.966 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -86.23 -67.43 0.81 Allowed 'General case' 0 C--N 1.355 0.841 0 CA-C-N 119.864 1.211 . . . . 72.42 111.893 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 t -61.16 153.08 26.84 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.67 1.123 . . . . 74.45 111.041 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -103.01 63.83 0.83 Allowed 'General case' 0 C--N 1.358 0.951 0 N-CA-C 109.304 -0.628 . . . . 75.43 109.304 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -125.71 161.24 27.75 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 116.274 -1.822 . . . . 74.53 107.053 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.3 m-85 -129.55 160.51 33.03 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.959 1.709 . . . . 72.52 109.862 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -81.26 151.62 69.72 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-O 116.294 -1.812 . . . . 72.33 107.953 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.359 1.111 0 CA-C-N 123.05 2.125 . . . . 74.24 108.886 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 118.783 -0.627 . . . . 73.42 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.18 28.69 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-O 119.039 -0.505 . . . . 73.32 110.408 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.47 167.03 12.7 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.978 -1.649 . . . . 64.31 108.978 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -123.72 15.17 9.43 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.421 0.718 . . . . 74.13 110.862 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.48 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.66 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 71.15 110.862 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 7.58 62.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 65.23 112.503 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.42 101.01 10.4 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 118.008 -3.054 . . . . 72.35 105.752 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -57.14 148.59 21.62 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.122 1.328 . . . . 73.44 109.189 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -68.86 -47.67 65.34 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.584 -1.265 . . . . 71.33 107.584 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -125.83 173.32 9.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.273 0.983 . . . . 72.44 109.055 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.0 mmt -72.98 -46.69 50.85 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 119.868 -0.733 . . . . 54.33 109.824 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -73.57 -66.65 0.67 Allowed 'General case' 0 C--N 1.355 0.817 0 CA-C-N 119.042 0.837 . . . . 73.44 111.813 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -60.47 167.9 2.37 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 119.694 1.134 . . . . 64.12 112.487 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.96 71.12 0.79 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.296 -1.372 . . . . 64.45 107.296 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -139.75 169.08 18.39 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.043 -1.932 . . . . 74.11 107.492 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 5' ' ' SER . 16.4 m-85 -137.62 159.36 42.19 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.886 1.675 . . . . 74.43 110.651 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -79.83 149.55 70.86 Favored Pre-proline 0 C--N 1.356 0.883 0 CA-C-O 116.222 -1.847 . . . . 74.42 107.274 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 C--N 1.359 1.127 0 CA-C-N 123.175 2.17 . . . . 74.41 110.092 179.319 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.408 -0.806 . . . . 71.21 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.02 27.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 CA-C-N 118.666 0.666 . . . . 71.23 110.015 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.33 166.13 13.27 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 108.965 -1.654 . . . . 64.31 108.965 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.38 15.16 9.67 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 124.375 0.691 . . . . 54.21 110.871 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -59.64 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.15 110.836 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 6.38 61.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 74.15 112.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.75 107.2 18.09 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 118.797 -2.59 . . . . 72.52 105.772 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.87 151.11 43.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.437 1.471 . . . . 63.42 108.629 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -71.11 -44.21 66.1 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.748 1.158 . . . . 74.14 108.109 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.9 p -135.41 165.16 26.12 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 123.796 0.685 . . . . 72.21 109.477 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.8 mmt -64.91 -43.49 92.67 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 118.746 -0.645 . . . . 73.45 109.932 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.1 m -76.99 -50.88 12.15 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 118.572 -0.727 . . . . 74.31 112.926 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -72.27 174.49 7.19 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 119.29 0.95 . . . . 51.45 111.968 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.55 42.16 2.34 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 118.626 -0.702 . . . . 74.11 110.407 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -118.94 168.76 10.49 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 116.984 -1.484 . . . . 75.33 108.142 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 5' ' ' SER . 29.4 m-85 -137.57 161.55 36.13 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.009 1.277 . . . . 72.51 109.93 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -81.74 150.46 66.11 Favored Pre-proline 0 C--N 1.356 0.853 0 CA-C-O 116.183 -1.865 . . . . 74.41 108.012 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.11 2.146 . . . . 55.33 108.607 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 119.232 -0.414 . . . . 71.42 111.066 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.84 30.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 0 CA-C-O 119.357 -0.354 . . . . 75.5 110.115 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.87 165.49 12.05 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 108.913 -1.675 . . . . 62.43 108.913 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.409 0.711 . . . . 73.23 110.831 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.1 m -59.75 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.86 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 7.07 61.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 52.5 112.48 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.91 102.54 11.97 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 120.119 -1.812 . . . . 73.1 107.231 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.25 150.34 26.04 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.948 1.249 . . . . 74.24 108.965 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.28 -44.89 64.34 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 119.386 0.994 . . . . 75.3 108.334 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -136.13 161.64 35.15 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.801 0.688 . . . . 72.33 109.955 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -58.01 -37.26 73.96 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 118.369 -0.824 . . . . 64.34 111.902 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -87.91 -53.55 4.69 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 118.995 0.816 . . . . 61.24 112.015 -168.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -71.54 171.34 11.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.473 -0.775 . . . . 73.22 110.521 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -118.17 53.15 0.97 Allowed 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.229 -1.026 . . . . 75.43 108.229 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -118.19 166.72 12.25 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.166 -1.79 . . . . 65.3 106.166 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.7 m-85 -134.84 160.8 37.06 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 120.039 1.29 . . . . 73.41 109.27 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -81.0 150.29 68.4 Favored Pre-proline 0 C--N 1.355 0.814 0 CA-C-O 116.426 -1.75 . . . . 75.24 107.731 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.359 1.131 0 CA-C-N 122.719 2.007 . . . . 65.22 108.883 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.682 -0.675 . . . . 73.23 111.444 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.18 30.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 CA-C-N 118.428 0.558 . . . . 65.23 110.048 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.84 165.1 12.07 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.079 -1.609 . . . . 51.21 109.079 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.02 15.18 9.93 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.406 0.709 . . . . 74.31 110.839 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 15.6 m -59.71 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 65.31 110.85 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.22 6.57 61.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 55.42 112.467 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.19 101.58 11.06 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.828 -1.984 . . . . 61.42 106.305 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.23 149.57 23.85 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.181 1.355 . . . . 71.42 109.811 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -70.47 -43.79 69.08 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.012 -1.107 . . . . 51.11 108.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -136.53 162.77 32.18 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 123.877 0.736 . . . . 62.41 109.85 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.4 mmt -61.38 -44.31 97.38 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.916 -0.564 . . . . 74.21 110.064 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 t -74.15 -52.77 11.5 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 112.966 0.728 . . . . 51.22 112.966 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -77.2 177.17 8.09 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.085 0.857 . . . . 73.41 112.62 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -119.14 55.94 0.93 Allowed 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.369 -0.974 . . . . 75.4 108.369 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 t -129.74 170.76 13.44 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 116.762 -1.59 . . . . 72.51 108.025 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 5' ' ' SER . 21.8 m-85 -139.63 161.04 38.48 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.916 1.235 . . . . 73.43 110.273 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -81.55 150.61 67.1 Favored Pre-proline 0 C--N 1.355 0.844 0 CA-C-O 116.522 -1.704 . . . . 73.22 107.788 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.36 1.14 0 CA-C-N 122.879 2.064 . . . . 61.24 110.019 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 118.69 -0.671 . . . . 74.25 111.67 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.42 30.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 CA-C-N 118.365 0.53 . . . . 75.24 109.901 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.76 164.95 12.01 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 109.023 -1.631 . . . . 72.21 109.023 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.01 15.27 9.94 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.375 0.691 . . . . 71.13 110.888 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.452 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.76 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.842 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 6.92 61.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 71.52 112.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.76 107.15 18.02 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 117.646 -3.267 . . . . 74.43 106.929 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.67 152.57 26.21 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.166 1.348 . . . . 75.41 109.038 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -71.81 -43.92 64.79 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.297 -1.001 . . . . 73.34 108.297 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.8 p -137.0 161.42 36.09 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 123.733 0.646 . . . . 72.24 109.925 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -36.49 84.13 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 118.433 -0.794 . . . . 54.24 111.517 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 t -80.48 -50.35 10.18 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 119.215 0.916 . . . . 53.14 112.182 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -72.54 -173.82 1.24 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.753 0.706 . . . . 75.4 111.505 -170.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.63 49.83 2.21 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.594 -0.891 . . . . 75.31 108.594 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -126.2 162.04 26.34 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 116.425 -1.75 . . . . 71.31 106.329 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.9 m-85 -130.57 161.59 31.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 120.831 1.65 . . . . 72.01 109.847 -172.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -79.65 151.0 73.8 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 116.122 -1.894 . . . . 73.34 107.577 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.359 1.092 0 CA-C-N 123.338 2.228 . . . . 62.13 108.641 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 119.216 -0.421 . . . . 73.5 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.36 31.73 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.818 -0.438 . . . . 72.31 109.818 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.27 166.0 12.1 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 108.73 -1.748 . . . . 52.2 108.73 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.68 14.89 9.44 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.371 0.689 . . . . 73.41 110.843 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 3.6 t -59.84 -171.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.841 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.63 6.81 59.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.32 112.509 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.98 110.68 22.93 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 119.68 -2.07 . . . . 73.21 105.608 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.76 151.26 47.02 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.465 1.484 . . . . 74.14 107.125 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -71.18 -52.22 20.42 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 p -126.17 162.63 24.95 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.001 0.813 . . . . 75.13 109.623 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -67.53 -32.93 74.06 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.373 -0.822 . . . . 64.43 111.874 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -83.36 -47.61 11.27 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.144 0.884 . . . . 45.14 112.584 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -75.26 -173.77 2.14 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 118.878 0.763 . . . . 71.11 111.571 -171.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.17 45.38 2.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.328 -0.619 . . . . 72.13 109.328 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -117.47 171.65 7.85 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 106.317 -1.734 . . . . 74.04 106.317 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.2 m-85 -137.96 162.02 35.16 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 120.101 1.319 . . . . 73.32 109.554 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.32 150.82 64.82 Favored Pre-proline 0 C--N 1.355 0.845 0 CA-C-O 116.485 -1.721 . . . . 65.32 108.048 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.36 1.134 0 CA-C-N 122.708 2.003 . . . . 52.14 108.835 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 CA--C 1.514 -0.414 0 CA-C-O 118.868 -0.587 . . . . 74.53 110.825 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.05 30.16 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.783 -0.451 . . . . 73.05 109.783 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.98 165.31 12.15 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 108.849 -1.7 . . . . 61.34 108.849 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.82 14.72 10.05 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 124.448 0.734 . . . . 73.1 110.894 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.495 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.8 -171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 53.14 110.831 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.73 59.1 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 70.45 112.475 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.94 114.98 29.62 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 117.41 -3.406 . . . . 64.23 105.243 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -66.84 150.84 48.59 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.984 1.72 . . . . 71.5 106.749 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.8 -50.91 38.4 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.4 -1.333 . . . . 62.43 107.4 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 p -128.59 162.13 28.01 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 123.946 0.779 . . . . 72.11 110.075 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -61.63 -39.15 90.26 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.265 -0.874 . . . . 72.32 111.897 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -83.45 -51.71 7.14 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 119.201 0.91 . . . . 63.34 111.895 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 t -70.0 175.45 4.43 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.944 0.793 . . . . 74.34 110.713 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -127.14 49.67 2.06 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.11 -1.07 . . . . 71.34 108.11 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -118.16 173.55 6.73 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.468 -1.678 . . . . 70.22 106.468 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.2 m-85 -138.59 161.24 37.59 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.746 1.612 . . . . 74.44 109.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -82.1 151.33 66.5 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.217 -1.849 . . . . 74.44 108.069 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.104 2.144 . . . . 51.22 108.646 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.834 -0.603 . . . . 72.44 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.63 31.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.848 -0.427 . . . . 62.55 109.848 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.44 166.94 12.32 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 108.935 -1.666 . . . . 75.45 108.935 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.0 14.8 9.2 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 124.432 0.724 . . . . 73.44 110.839 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.2 t -59.83 -172.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.873 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.33 58.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.761 . . . . 62.52 112.465 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.69 115.85 31.24 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 118.535 -2.744 . . . . 74.23 105.599 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.21 150.22 48.57 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.862 1.664 . . . . 74.31 106.74 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.26 -45.99 65.29 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 119.905 1.23 . . . . 71.35 108.312 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -130.37 167.15 19.01 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.008 0.817 . . . . 74.55 109.145 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.4 mmt -69.13 -38.56 78.92 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 118.374 -0.822 . . . . 52.22 110.42 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 t -82.86 -52.76 6.43 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.132 0.878 . . . . 44.13 112.524 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -70.67 177.19 3.65 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 119.51 1.05 . . . . 63.02 112.028 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 pm0 -121.2 49.01 1.55 Allowed 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.246 -0.65 . . . . 75.32 109.246 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -118.67 171.03 8.47 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 116.899 -1.524 . . . . 54.42 107.884 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 5' ' ' SER . 19.1 m-85 -139.28 160.18 40.43 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.038 1.29 . . . . 71.42 110.238 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -81.96 151.06 66.59 Favored Pre-proline 0 C--N 1.356 0.884 0 CA-C-O 116.358 -1.782 . . . . 72.34 108.151 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 C--N 1.36 1.174 0 CA-C-N 122.793 2.033 . . . . 74.11 110.133 179.241 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 118.875 -0.583 . . . . 72.2 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.75 33.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.696 -0.483 . . . . 62.53 109.696 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.65 12.18 Favored Glycine 0 C--N 1.354 1.537 0 N-CA-C 109.047 -1.621 . . . . 72.04 109.047 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.69 15.14 9.45 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 124.397 0.704 . . . . 65.13 110.823 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -59.67 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 54.42 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.27 6.2 61.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.3 112.49 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.49 102.72 12.17 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 119.203 -2.351 . . . . 54.21 106.09 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -57.48 150.42 18.8 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.099 1.318 . . . . 72.0 109.438 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -71.44 -51.32 24.5 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 107.36 -1.348 . . . . 73.21 107.36 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 p -125.72 162.77 24.3 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.045 0.841 . . . . 74.31 109.829 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -64.68 -35.42 80.97 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.375 -0.821 . . . . 73.11 111.788 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -85.74 -51.2 6.59 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 119.074 0.852 . . . . 73.14 112.298 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -72.89 176.82 5.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.098 0.863 . . . . 71.44 111.811 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 52.44 1.25 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.728 -0.842 . . . . 71.15 108.728 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 t -122.91 170.51 10.05 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 116.799 -1.572 . . . . 75.13 107.499 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 5' ' ' SER . 23.9 m-85 -138.62 161.07 38.05 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 119.924 1.238 . . . . 71.04 109.905 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -82.49 151.52 65.52 Favored Pre-proline 0 C--N 1.355 0.833 0 CA-C-O 116.391 -1.766 . . . . 72.04 108.268 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 C--N 1.361 1.206 0 CA-C-N 122.762 2.022 . . . . 75.34 108.812 -179.729 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.522 -0.751 . . . . 34.31 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.7 28.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 118.4 0.545 . . . . 53.14 110.093 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.78 166.15 12.49 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.124 -1.59 . . . . 71.02 109.124 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.51 15.19 9.58 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 124.458 0.74 . . . . 64.13 110.917 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -59.64 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.881 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.52 62.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 51.45 112.446 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.2 mt -107.22 99.29 8.84 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 119.105 -2.409 . . . . 71.05 106.981 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -54.71 150.32 9.78 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 119.627 1.103 . . . . 75.4 109.729 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -72.21 -50.51 26.96 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 107.5 -1.296 . . . . 75.25 107.5 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.4 p -128.75 160.75 31.55 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 123.91 0.756 . . . . 65.23 110.137 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -60.41 -38.55 84.37 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 118.235 -0.888 . . . . 73.3 112.197 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 t -82.53 -52.92 6.39 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.311 0.959 . . . . 63.43 111.494 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -70.14 169.24 13.96 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 118.733 0.697 . . . . 70.04 111.414 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -119.66 65.74 0.8 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.518 -1.66 . . . . 33.35 106.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 t -139.31 161.08 38.32 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 115.646 -2.121 . . . . 74.24 106.415 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 5' ' ' SER . 20.8 m-85 -132.61 161.29 34.25 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.804 2.093 . . . . 71.13 110.612 -169.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.45 150.64 70.81 Favored Pre-proline 0 C--N 1.357 0.914 0 CA-C-O 116.322 -1.799 . . . . 73.32 107.64 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 C--N 1.359 1.123 0 CA-C-N 123.048 2.124 . . . . 74.0 108.584 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.533 -0.746 . . . . 35.1 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.89 30.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 118.521 0.6 . . . . 52.55 109.898 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.56 165.74 12.09 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.084 -1.606 . . . . 51.14 109.084 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.61 15.08 9.51 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 124.435 0.727 . . . . 75.12 110.875 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.44 110.866 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 8.12 62.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 63.12 112.465 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.99 99.29 8.75 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 118.843 -2.563 . . . . 73.55 106.072 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -55.04 148.11 14.42 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 119.8 1.182 . . . . 72.11 109.279 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.22 -46.75 66.62 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 107.498 -1.297 . . . . 74.14 107.498 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.9 p -127.12 171.54 11.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.208 0.943 . . . . 61.35 109.932 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -33.73 65.81 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 117.499 -1.239 . . . . 74.32 111.35 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -90.73 -61.98 1.55 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.366 1.439 . . . . 55.01 111.476 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -61.48 173.69 0.88 Allowed 'General case' 0 C--N 1.353 0.749 0 CA-C-N 119.265 0.939 . . . . 53.21 112.767 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -120.3 58.37 0.92 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.375 -0.972 . . . . 72.24 108.375 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 t -130.5 170.77 13.79 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 116.552 -1.69 . . . . 62.22 108.079 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.6 m-85 -138.47 160.21 40.11 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 120.131 1.332 . . . . 73.44 110.206 -172.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -80.61 151.1 71.09 Favored Pre-proline 0 C--N 1.357 0.893 0 CA-C-O 116.194 -1.86 . . . . 73.12 107.807 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.36 1.144 0 CA-C-N 123.279 2.207 . . . . 72.35 108.705 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 119.049 -0.501 . . . . 74.51 111.291 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.71 29.57 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-O 119.184 -0.436 . . . . 72.54 110.016 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.0 165.18 12.12 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 108.673 -1.771 . . . . 41.22 108.673 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.63 15.15 10.25 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 124.379 0.693 . . . . 74.43 110.862 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.61 -172.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 72.43 110.834 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.26 7.9 62.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 73.42 112.541 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.04 98.13 7.48 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 118.627 -2.69 . . . . 70.24 106.32 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtm-85 -55.6 148.49 15.81 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-N 119.717 1.144 . . . . 72.15 110.578 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -70.65 -45.12 65.71 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 108.405 -0.961 . . . . 73.53 108.405 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.5 p -135.5 160.05 39.7 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.841 0.713 . . . . 73.41 109.849 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -60.2 -38.09 82.27 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.386 -0.816 . . . . 65.45 111.747 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -82.65 -53.23 6.09 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 119.03 0.832 . . . . 43.3 112.732 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 t -71.81 175.04 6.09 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-N 119.192 0.905 . . . . 73.33 111.548 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -119.68 48.55 1.51 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 108.863 -0.791 . . . . 73.32 108.863 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -120.22 167.49 12.21 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.01 -1.478 . . . . 71.45 107.01 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' SER . 30.2 m-85 -135.42 161.03 36.59 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 119.748 1.158 . . . . 71.35 109.048 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -81.65 151.36 68.08 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 116.368 -1.777 . . . . 61.13 107.968 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--N 1.36 1.175 0 CA-C-N 122.875 2.063 . . . . 64.24 108.59 179.525 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.656 -0.687 . . . . 63.34 111.522 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.78 29.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.393 0.542 . . . . 71.23 110.086 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.23 165.69 12.34 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 108.919 -1.673 . . . . 70.1 108.919 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -123.16 15.22 9.83 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.487 0.757 . . . . 62.12 110.865 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.65 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 70.05 110.833 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.18 7.61 62.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.786 -0.721 . . . . 70.14 112.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.05 102.72 11.68 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 118.442 -2.799 . . . . 75.43 105.625 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm-85 -58.39 149.37 25.0 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 120.24 1.382 . . . . 72.4 109.055 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.41 -46.45 66.81 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.47 -1.308 . . . . 73.12 107.47 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.4 p -128.06 169.12 14.41 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.216 0.948 . . . . 75.3 109.734 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.4 ptp -72.27 -30.05 64.47 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.296 -1.335 . . . . 74.23 111.918 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -92.44 -65.45 1.0 Allowed 'General case' 0 C--N 1.356 0.89 0 CA-C-N 120.483 1.492 . . . . 65.44 111.816 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 t -59.64 154.99 16.52 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.722 1.146 . . . . 73.44 112.419 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -96.82 49.85 1.09 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-O 118.693 -0.67 . . . . 73.34 112.147 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -121.66 169.92 10.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-O 116.56 -1.686 . . . . 75.44 109.456 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.2 m-85 -137.55 158.57 44.11 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.945 1.248 . . . . 74.23 110.519 -172.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -80.38 151.07 71.75 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.124 -1.893 . . . . 74.43 107.843 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.36 1.141 0 CA-C-N 123.215 2.184 . . . . 54.34 108.473 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.222 -0.372 0 CA-C-O 118.804 -0.617 . . . . 71.51 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.05 26.27 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 119.003 -0.522 . . . . 71.43 110.334 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.45 165.5 13.1 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 108.71 -1.756 . . . . 65.13 108.71 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.81 15.22 10.1 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 124.409 0.711 . . . . 70.05 110.849 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.4 m -59.69 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 52.11 110.866 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.17 7.09 62.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 32.05 112.517 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.1 95.65 5.92 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.575 -1.544 . . . . 64.51 106.866 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -53.99 147.78 11.86 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 119.828 1.194 . . . . 73.01 109.549 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -70.34 -47.3 61.67 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 107.585 -1.265 . . . . 73.14 107.585 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -127.32 169.4 13.6 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 124.044 0.84 . . . . 74.32 109.902 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -70.71 -34.98 72.51 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 118.242 -0.885 . . . . 63.15 111.638 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -86.47 -67.79 0.79 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.332 0.969 . . . . 73.34 111.387 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 171.24 0.32 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.107 0.78 . . . . 64.22 113.107 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.42 43.12 2.42 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.563 0.539 . . . . 70.45 110.909 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -114.98 168.63 9.75 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-O 116.984 -1.484 . . . . 73.12 107.559 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.4 m-85 -135.58 160.48 38.37 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.032 1.287 . . . . 62.1 109.487 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -81.11 151.09 69.57 Favored Pre-proline 0 C--N 1.356 0.865 0 CA-C-O 116.244 -1.836 . . . . 72.44 107.742 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.361 1.186 0 CA-C-N 123.02 2.114 . . . . 75.55 108.52 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.513 -0.454 0 CA-C-O 118.836 -0.602 . . . . 73.42 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.82 33.47 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 109.863 -0.421 . . . . 73.31 109.863 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.52 166.09 12.12 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 109.223 -1.551 . . . . 75.43 109.223 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.27 15.08 9.74 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.325 0.662 . . . . 75.44 110.827 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.72 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.861 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 7.45 62.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 71.15 112.477 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.15 105.23 14.87 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 118.462 -2.787 . . . . 72.42 105.491 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -61.85 149.03 41.42 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.36 1.436 . . . . 75.45 107.779 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -68.66 -44.51 73.95 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 107.392 -1.336 . . . . 72.22 107.392 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.5 p -129.47 171.08 12.91 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.049 0.843 . . . . 60.11 109.606 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 mmt -72.23 -36.71 69.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 117.931 -1.033 . . . . 43.21 110.966 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -86.23 -67.43 0.81 Allowed 'General case' 0 C--N 1.355 0.841 0 CA-C-N 119.864 1.211 . . . . 72.42 111.893 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 t -61.16 153.08 26.84 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 119.67 1.123 . . . . 74.45 111.041 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -103.01 63.83 0.83 Allowed 'General case' 0 C--N 1.358 0.951 0 N-CA-C 109.304 -0.628 . . . . 75.43 109.304 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -125.71 161.24 27.75 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 116.274 -1.822 . . . . 74.53 107.053 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.3 m-85 -129.55 160.51 33.03 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.959 1.709 . . . . 72.52 109.862 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -81.26 151.62 69.72 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-O 116.294 -1.812 . . . . 72.33 107.953 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.359 1.111 0 CA-C-N 123.05 2.125 . . . . 74.24 108.886 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 118.783 -0.627 . . . . 73.42 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.18 28.69 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-O 119.039 -0.505 . . . . 73.32 110.408 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.47 167.03 12.7 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.978 -1.649 . . . . 64.31 108.978 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -123.72 15.17 9.43 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.421 0.718 . . . . 74.13 110.862 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.48 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.66 -172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 71.15 110.862 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 7.58 62.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 65.23 112.503 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.42 101.01 10.4 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 118.008 -3.054 . . . . 72.35 105.752 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -57.14 148.59 21.62 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.122 1.328 . . . . 73.44 109.189 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -68.86 -47.67 65.34 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.584 -1.265 . . . . 71.33 107.584 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.9 p -125.83 173.32 9.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 124.273 0.983 . . . . 72.44 109.055 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.0 mmt -72.98 -46.69 50.85 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 119.868 -0.733 . . . . 54.33 109.824 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -73.57 -66.65 0.67 Allowed 'General case' 0 C--N 1.355 0.817 0 CA-C-N 119.042 0.837 . . . . 73.44 111.813 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -60.47 167.9 2.37 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 119.694 1.134 . . . . 64.12 112.487 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.96 71.12 0.79 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.296 -1.372 . . . . 64.45 107.296 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -139.75 169.08 18.39 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.043 -1.932 . . . . 74.11 107.492 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 5' ' ' SER . 16.4 m-85 -137.62 159.36 42.19 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 120.886 1.675 . . . . 74.43 110.651 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -79.83 149.55 70.86 Favored Pre-proline 0 C--N 1.356 0.883 0 CA-C-O 116.222 -1.847 . . . . 74.42 107.274 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 C--N 1.359 1.127 0 CA-C-N 123.175 2.17 . . . . 74.41 110.092 179.319 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.408 -0.806 . . . . 71.21 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.02 27.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 CA-C-N 118.666 0.666 . . . . 71.23 110.015 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.33 166.13 13.27 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 108.965 -1.654 . . . . 64.31 108.965 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.38 15.16 9.67 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 124.375 0.691 . . . . 54.21 110.871 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -59.64 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.15 110.836 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.29 6.38 61.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 74.15 112.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.75 107.2 18.09 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 118.797 -2.59 . . . . 72.52 105.772 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.87 151.11 43.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.437 1.471 . . . . 63.42 108.629 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -71.11 -44.21 66.1 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.748 1.158 . . . . 74.14 108.109 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.9 p -135.41 165.16 26.12 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 123.796 0.685 . . . . 72.21 109.477 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.8 mmt -64.91 -43.49 92.67 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 118.746 -0.645 . . . . 73.45 109.932 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.1 m -76.99 -50.88 12.15 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 118.572 -0.727 . . . . 74.31 112.926 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -72.27 174.49 7.19 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 119.29 0.95 . . . . 51.45 111.968 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.55 42.16 2.34 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 118.626 -0.702 . . . . 74.11 110.407 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -118.94 168.76 10.49 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 116.984 -1.484 . . . . 75.33 108.142 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 5' ' ' SER . 29.4 m-85 -137.57 161.55 36.13 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.009 1.277 . . . . 72.51 109.93 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -81.74 150.46 66.11 Favored Pre-proline 0 C--N 1.356 0.853 0 CA-C-O 116.183 -1.865 . . . . 74.41 108.012 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.11 2.146 . . . . 55.33 108.607 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 119.232 -0.414 . . . . 71.42 111.066 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.84 30.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 0 CA-C-O 119.357 -0.354 . . . . 75.5 110.115 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.87 165.49 12.05 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 108.913 -1.675 . . . . 62.43 108.913 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.409 0.711 . . . . 73.23 110.831 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 5.1 m -59.75 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.86 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 7.07 61.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 52.5 112.48 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.91 102.54 11.97 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 120.119 -1.812 . . . . 73.1 107.231 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.25 150.34 26.04 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.948 1.249 . . . . 74.24 108.965 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.28 -44.89 64.34 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 119.386 0.994 . . . . 75.3 108.334 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -136.13 161.64 35.15 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.801 0.688 . . . . 72.33 109.955 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -58.01 -37.26 73.96 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 118.369 -0.824 . . . . 64.34 111.902 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -87.91 -53.55 4.69 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 118.995 0.816 . . . . 61.24 112.015 -168.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -71.54 171.34 11.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.473 -0.775 . . . . 73.22 110.521 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -118.17 53.15 0.97 Allowed 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.229 -1.026 . . . . 75.43 108.229 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -118.19 166.72 12.25 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.166 -1.79 . . . . 65.3 106.166 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 5' ' ' SER . 27.7 m-85 -134.84 160.8 37.06 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 120.039 1.29 . . . . 73.41 109.27 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -81.0 150.29 68.4 Favored Pre-proline 0 C--N 1.355 0.814 0 CA-C-O 116.426 -1.75 . . . . 75.24 107.731 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.359 1.131 0 CA-C-N 122.719 2.007 . . . . 65.22 108.883 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.682 -0.675 . . . . 73.23 111.444 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.18 30.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 CA-C-N 118.428 0.558 . . . . 65.23 110.048 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.84 165.1 12.07 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.079 -1.609 . . . . 51.21 109.079 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.02 15.18 9.93 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.406 0.709 . . . . 74.31 110.839 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 15.6 m -59.71 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 65.31 110.85 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.22 6.57 61.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 55.42 112.467 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.19 101.58 11.06 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.828 -1.984 . . . . 61.42 106.305 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.23 149.57 23.85 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.181 1.355 . . . . 71.42 109.811 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -70.47 -43.79 69.08 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.012 -1.107 . . . . 51.11 108.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -136.53 162.77 32.18 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 123.877 0.736 . . . . 62.41 109.85 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.4 mmt -61.38 -44.31 97.38 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.916 -0.564 . . . . 74.21 110.064 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 t -74.15 -52.77 11.5 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 112.966 0.728 . . . . 51.22 112.966 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -77.2 177.17 8.09 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.085 0.857 . . . . 73.41 112.62 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -119.14 55.94 0.93 Allowed 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.369 -0.974 . . . . 75.4 108.369 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 t -129.74 170.76 13.44 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 116.762 -1.59 . . . . 72.51 108.025 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 5' ' ' SER . 21.8 m-85 -139.63 161.04 38.48 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.916 1.235 . . . . 73.43 110.273 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -81.55 150.61 67.1 Favored Pre-proline 0 C--N 1.355 0.844 0 CA-C-O 116.522 -1.704 . . . . 73.22 107.788 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.36 1.14 0 CA-C-N 122.879 2.064 . . . . 61.24 110.019 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 118.69 -0.671 . . . . 74.25 111.67 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.42 30.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 CA-C-N 118.365 0.53 . . . . 75.24 109.901 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.76 164.95 12.01 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 109.023 -1.631 . . . . 72.21 109.023 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.01 15.27 9.94 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.375 0.691 . . . . 71.13 110.888 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.452 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -59.76 -172.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.842 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 6.92 61.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 71.52 112.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.76 107.15 18.02 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 117.646 -3.267 . . . . 74.43 106.929 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.67 152.57 26.21 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.166 1.348 . . . . 75.41 109.038 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -71.81 -43.92 64.79 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.297 -1.001 . . . . 73.34 108.297 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.8 p -137.0 161.42 36.09 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 123.733 0.646 . . . . 72.24 109.925 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -36.49 84.13 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 118.433 -0.794 . . . . 54.24 111.517 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 t -80.48 -50.35 10.18 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 119.215 0.916 . . . . 53.14 112.182 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -72.54 -173.82 1.24 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.753 0.706 . . . . 75.4 111.505 -170.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.63 49.83 2.21 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.594 -0.891 . . . . 75.31 108.594 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 t -126.2 162.04 26.34 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 116.425 -1.75 . . . . 71.31 106.329 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 5' ' ' SER . 25.9 m-85 -130.57 161.59 31.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 120.831 1.65 . . . . 72.01 109.847 -172.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -79.65 151.0 73.8 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 116.122 -1.894 . . . . 73.34 107.577 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.359 1.092 0 CA-C-N 123.338 2.228 . . . . 62.13 108.641 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 119.216 -0.421 . . . . 73.5 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.36 31.73 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.818 -0.438 . . . . 72.31 109.818 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.27 166.0 12.1 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 108.73 -1.748 . . . . 52.2 108.73 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.68 14.89 9.44 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.371 0.689 . . . . 73.41 110.843 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 3.6 t -59.84 -171.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.841 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.63 6.81 59.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.32 112.509 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.98 110.68 22.93 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 119.68 -2.07 . . . . 73.21 105.608 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.76 151.26 47.02 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.465 1.484 . . . . 74.14 107.125 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -71.18 -52.22 20.42 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 p -126.17 162.63 24.95 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.001 0.813 . . . . 75.13 109.623 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -67.53 -32.93 74.06 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.373 -0.822 . . . . 64.43 111.874 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -83.36 -47.61 11.27 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.144 0.884 . . . . 45.14 112.584 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -75.26 -173.77 2.14 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 118.878 0.763 . . . . 71.11 111.571 -171.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.17 45.38 2.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.328 -0.619 . . . . 72.13 109.328 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -117.47 171.65 7.85 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 106.317 -1.734 . . . . 74.04 106.317 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 5' ' ' SER . 24.2 m-85 -137.96 162.02 35.16 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 120.101 1.319 . . . . 73.32 109.554 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.32 150.82 64.82 Favored Pre-proline 0 C--N 1.355 0.845 0 CA-C-O 116.485 -1.721 . . . . 65.32 108.048 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.36 1.134 0 CA-C-N 122.708 2.003 . . . . 52.14 108.835 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 CA--C 1.514 -0.414 0 CA-C-O 118.868 -0.587 . . . . 74.53 110.825 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.05 30.16 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.783 -0.451 . . . . 73.05 109.783 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.98 165.31 12.15 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 108.849 -1.7 . . . . 61.34 108.849 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.82 14.72 10.05 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 124.448 0.734 . . . . 73.1 110.894 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.495 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -59.8 -171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 53.14 110.831 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.64 6.73 59.1 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 70.45 112.475 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.94 114.98 29.62 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 117.41 -3.406 . . . . 64.23 105.243 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -66.84 150.84 48.59 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.984 1.72 . . . . 71.5 106.749 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.8 -50.91 38.4 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.4 -1.333 . . . . 62.43 107.4 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 p -128.59 162.13 28.01 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 123.946 0.779 . . . . 72.11 110.075 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -61.63 -39.15 90.26 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.265 -0.874 . . . . 72.32 111.897 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -83.45 -51.71 7.14 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 119.201 0.91 . . . . 63.34 111.895 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 t -70.0 175.45 4.43 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.944 0.793 . . . . 74.34 110.713 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -127.14 49.67 2.06 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.11 -1.07 . . . . 71.34 108.11 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -118.16 173.55 6.73 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.468 -1.678 . . . . 70.22 106.468 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 5' ' ' SER . 22.2 m-85 -138.59 161.24 37.59 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.746 1.612 . . . . 74.44 109.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -82.1 151.33 66.5 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.217 -1.849 . . . . 74.44 108.069 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.36 1.168 0 CA-C-N 123.104 2.144 . . . . 51.22 108.646 -179.862 . . . . . . . . 0 0 . 1 stop_ save_